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Soybeans are known for its high protein content that could be substituted to animal 
proteins. The potential bioactive properties of mature soybean (MS) proteins and their 
hydrolysates have been widely explored. The aim of this study was to investigate and 
compare various in-vitro bioactive properties (antioxidant, anti-diabetic, anti-obesity, 
and anti-inflammatory) of young soybean (YS) and MS flour and their protein 
hydrolysates when subjected to in-vitro simulated gastrointestinal digestion (SGID) 
and enzymatic hydrolysis, respectively. In the first phase, SGID of YS and MS flour 
was carried out to mimic the human digestion, while in the second phase, enzymatic 
hydrolysis of the soybean protein isolate was carried out by alcalase, bromelain, and 
flavourzyme for 2, 4, and 6 h in order to produce different protein hydrolysates. The 
results showed that upon in-vitro SGID, the total phenolic content (TPC) significantly 
increased, and was higher in YS compared to MS (P<0.05). YS and MS flours varied 
in their inhibitory activity against -amylase (AA), dipeptidyl peptidase IV (DPP-IV), 
pancreatic lipase (LIP), and cholesterol esterase (CE) enzymes when subjected to 
simulated gastric digestion (P<0.05) followed by a decrease in the inhibitory activity 
upon simulated intestinal digestion stage. Furthermore, MS flour exhibited higher 
antioxidant and anti-inflammatory (AI) activities than YS when subjected to SGID 
(P<0.05). The results of the enzymatic hydrolysis in the second phase revealed that the 
YS and MS protein hydrolysates displayed enhanced inhibitory activity against AA, 
DPP-IV, LIP, and CE enzymes when hydrolyzed by different enzymes for different 
time periods (P<0.05). Antioxidant and AI activities were also found to be higher in 
hydrolysates compared to intact proteins for both YS and MS proteins (P<0.05). In 
conclusion, the bioactive properties of YS and MS flour upon SGID and proteins upon 
enzymatic hydrolysis were enhanced compared to unhydrolyzed samples. Further 
research is needed to identify the sequence of bioactive peptides responsible for 
different bioactive properties of YS and MS proteins.  
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Title and Abstract (in Arabic) 
 
اً اصف ا ط  ص ا ا  فصا ص را ص ا ا زات  ا در
م اص  ت ا ر  ا
 صا
ات ُ ت اُ ص ُا ُ اتُُار ت ر ُا ُ ُت ُأ ُ ت اتُا ت ر ُا ُ ا ا
اُ ص ُا ُ ات ت ر ُ ة ت ُا ًا ج ُ طة ُا ص صا ُا ا ت ُا ُت ة. ا ا
ُ د ُ ا زات ُدر ُ ة درا ُا ذ ُ ُ د ُا ا ُ . ا ُ طا ُ ُ ا ُا ا ثت ُا
ًُ ج ُ طة صُا صا ُا ت ُ ُ ة ار ضادةُا ُ دة، ضاداتُا (ُ ر ت ُا ُ ا
اضجُ ا رُ ص ُا ا ص ُا ُ د ُ ات( ا ت ُ ضادة ة،ُ ُ ضادة ُ، ر رضُا
زات اصةُُدر ُا ت ر رضُا ُت ضُد ةُا ةُ د ُ اة رُا ت  ُا
ت .ُا ز ُا ا ُإجراءُا ،ُت ةُا ر اةُُا ضُا ةُا ةُ ُُد ُد
ر ص ُا ا ص اضج ا ُ ا ت ُا ُإجراء ُت ة، ثا ُا ة ر ُا ُ ا ُ ، ر ُا ض ُا اة ا
ُ ز ُا ا تا اُُر ص ُُا ر ص اضجا زُا ُُا طة ثُا ُث دا ت ا
ُ ت ر ةُ اتُ ز دةُُ-إ ُ رز ُ، ر ز،ُ ا ات2ُ4ُ6ُأ تاجُُا ُإ ُأج
ت ُ ت ر ُ دُ.ُت ُ جُأ تا رتُا ضإجراءُأظ ةُا ةُ د اةُ رُا ت  ُا
ُا ُا ت ُ زادُا ةُ ار رُ ص اُا ص ُا ُ ُ ُأ ا ُ، ُ
اضج ا ُا ص ُ.ُا رُد ًطُاُأظ ث اًطُا اضجُ ا رُ ص ا ُا ص اًُا اُت اتُأ ز ضدُأ
تر ترازُا از،ُإ ا ُ، را دازُا ت ُ د ت د ز،ُ رض أ ُُدُت ض اةُا ا
د ُا ا ض ةُا ر اُة ا ُد طُ ث اطُا ُا اضُ رُُ.ُا ،ُأظ ُذ ُة
اُا ص ُا ُ دةُد ضاداتُا اتاضجُ ا ت ضادةُ رُُُأ ا ص اُا ص ُا
رضُ ت ضُإدُا ةُا ةُ د اةُ رأُ.ا جظ تا ُاُتُ ُت ز ُا ا ُا ُ ت ر
ًطاُ ث اًطاُ اضجُ ا رُ ص اُا ص اتُززاًُا ز ،ُ ضدُإ را دازُا ت ُ د ت د ز،ُ اُأ أ
از، ترُا ُا تراز اتُإ ز ُت إ ةُُد تراتُز ُ ة ت اتُ ز ُإ طة ا
ُ دة ُا ضادات صُ صا ُ ُ ر ث ُا ُت ة. طةت ُُأ ُ ُأ ات ا ت ُ ضادة ا
ُ ت ر ُا زات رُدر ص ُا ا ص ُا ُ ات ت ر ُ ُ ُ ة ُا ات ت ر ا ُ ة ار
اضج. ُ ا ،ُت تا اضجُُا ا رُ ص اُا ص ُا ُ د ًاُ ج طةُ صُا صا ُا ت




ةُ ؤ ًاُا ج طةُ داتُا ت ُا دُت د ت ثُ ُا دُ ز ُ اجةُإ ُ ا ة.ُ ت رُا
صُا صا ةُا ت ًاُا ج اضج.ُُطةُ ا رُ ص اُا ص ُا اتُ ت ُر
ر ث ا م ا ا،ُفا ص ُا ر،ُ:ُ ص اُا ص تُا زات،ُاتر اةُ،ُدر ا
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Chapter 1: Introduction 
 
1.1 Overview 
Soybean (Glycine max) L. is an important crop worldwide, which is an 
excellent source of protein for human consumption (Berk, 1992). More than 50% of 
the so bean orld s production is accounted to the United States of America (USA) 
(Palomo et al., 2011). Soybean is a leguminous plant native to Eastern Asia, north and 
central China. Later the cultivated varieties were introduced into Korea and Japan 
approximately before 2000 years ago. Until this day, soybean is consumed as an 
essential component of different region s traditional diets (Berk, 1992). The demand 
for soybean is increasing worldwide, because for various reasons such as it is one of 
the oils crops, it is also used for feed for livestock and aquaculture, and as an important 
source of protein and biodiesel feedstock (Masuda & Goldsmith, 2009). 
There are a variety of products being produced from soybean including 
fermented products such as soy sauce, tempeh, miso, and douche (Chatterjee et al., 
2018), soy flour, tofu, soy milk, oil, edamame (green soybean) (Agyei, 2015), Soybean 
is composed of ~35 40% protein, ~20% lipids, ~9% dietary fiber, and ~8.5% moisture 
based on the dry weight of mature raw seeds (Chatterjee et al., 2018). In addition, 
soybean contains different components that are known to have a biological activity 
such as proteins or peptides, isoflavones, saponins, and protease inhibitors (Isanga & 
Zhang, 2008). Moreover, soybean varieties may differ in the color of their mature 
pods, and the brown and tan colors are the most common (Fehr & Caviness, 1977). 
The soybean is considered mature when it reaches R8 (Full maturity stage), unlike the 
young soybean which is harvested before full maturity when the green seeds are fully 




In Asian cultures, young soybean consumption has remained a favorite for 
many years, especially in Japan for 400 years (Wszelaki et al., 2005). Moreover, the 
popularity of young soybean has been seen a recent surge in its consumption especially 
in the USA due to its health-related functional properties (Mozzoni & Chen, 2019), 
and also is considered a functional food crop because it is rich in phytochemicals and 
is high in nutrients, that are beneficial to human health (Mentreddy et al., 2002). The 
young soybean seeds contain (22 32%) protein, (16 22%) oil, traces of 
oligosaccharides (dry weight basis) (Mozzoni & Chen, 2019). In addition, it contains 
phospholipids, iron, calcium dietary fibers (Hu et al., 2006), isoflavones and 
tocopherols (vitamin E) in dried seeds, and high fractions of monosaturated fatty acids 
in fresh green seeds (Mentreddy et al., 2002). 
Soy proteins are high biological value proteins due to the presence of all 
essential amino acids and can be potentially used as an alternative to animal proteins 
(Singh et al., 2014). The t o major storage so  proteins are gl cinin (11S) and -
conglycinin (7S) that accounts 80-90% of the whole protein, whereas the minor storage 
proteins include the lectin, Kunitz, and Bowman-Brik protease inhibitors. 
Furthermore, different ratios of gl cinin and -conglycinin in soy protein may have 
different nutritional and physiological effects (Chatterjee et al., 2018). 
Bioactive peptides have been associated with several positive health benefits 
including antihypertensive, anti-diabetic, anti-obesity, relaxing and, satiety-inducing 
effects (Hayes & Tiwari, 2015). Bioactive peptides are defined as specific protein 
fragments of 2-20 amino acids, linked covalently by peptide linkage and have a 
positive impact on body functions or conditions and may influence health (Sánchez & 
Vázquez, 2017). These peptides have to be bioavailable and able to exert the health 




Consumption of the commercial synthetic drugs such as the anti-inflammatory 
(AI), antihypertensive, antidiabetic, and antioxidants drugs may result in side effects 
with the prolonged usage. Therefore, the interest of utilizing natural compounds in 
therapeutic applications is increasing with an aim to have a safer alternative 
(Chakrabarti et al., 2014). Bioactive peptides can be used as a functional food 
ingredient and could be used to prevent diseases rather than treatment (Hayes & 
Tiwari, 2015). 
Soybean peptides are well known for therapeutic role by acting as 
antihypertensive, anticancer, anti-obesity and, hypocholestromic agents. Thus, these 
bioactive peptides are being investigated to create functional foods ingredients and 
drugs due to their bio-functional activity (Singh et al., 2014). The soy-derived peptides 
remained inactive inside their parent proteins sequence (Chatterjee et al., 2018), and 
become biologically active upon their release by proteolytic enzymes present in 
different biological processes such as gastrointestinal digestion and microbial 
proteolysis (Agyei, 2015).  
1.2 Statement of the problem 
Consumption of soybean either as an intact protein or as a bioactive peptide 
has been related to various beneficial health effects especially in reducing chronic 
diseases including insulin-resistance and type II diabetes, obesity, cardiovascular 
disease, and some types of cancers (Chatterjee et al., 2018). Currently, the soy peptides 
are being a subject of research of functional food ingredients and new drugs to regulate 
the absorption of nutrients and gut health due to their bioactive properties (Singh et 
al., 2014). On the other hand, there is a lack in research in the investigation of the 
hydrolysates possessing bioactive properties of young soybean either produced via 




soybean upon proteolysis were investigated for their antihypertensive activity, which 
could become an ingredient for the development of functional foods (Hanafi et al., 
2018). Till date studies related with protein hydrolysates from young soybean proteins 
and their bioactive properties are scarce. Thus, this research was designed to explore 
comparative investigation on hydrolysates from proteins derived from young (YS) and 
mature soybean (MS) and to investigate their bioactive properties. The objectives of 
the study were to explore and compare the bioactive properties of YS and MS and their 
protein hydrolysates upon in-vitro gastrointestinal digestion and enzymatic hydrolysis. 
1.3 Relevant literature 
Soybean (Glycine max (L.) Merrill) belongs to Leguminosae family and is an 
annual growing plant with a height ranging from 0.50 to 1.25 m. Morphologically, the 
seeds of the soybeans are varying in shape (oval, spherical) and color and mostly 
present in yellowish color (Liu, 2004). In the first half of the 20th century, China was 
the prime producer and exporter of soybean (Qiu & Chang, 2010). In the 1950s, 
soybean production was increased rapidly in different regions of the USA. Now, the 
USA is the largest producer of soybean worldwide, followed by Brazil, and Argentina 
(Qiu & Chang, 2010). Soybean crop is rich in protein content, phytochemicals, 
essential fatty acids, vitamins, minerals, and antioxidants (Palomo et al., 2011).  
The production of young soybean has flourished and expanded sharply in 
recent decades as a result of increased interest and awareness to its nutritional 
properties, and high consumption to maintain a healthier lifestyle. In the U.S, 
particularly in the 1980s, the importation of frozen young soybean increased from 300 
 500 tons per year, followed by an increment to 10,000 tons in 2000, and to 25,000 




young soybean to outgrow other soy products by 2020, to have a healthier and 
inexpensive source of protein in the diet (Zhang et al., 2017). 
Young soybean has a shorter growing season and is usually harvested at 
immature stage (full seed stage) (R6) than mature soybean which is harvested at 
reproductive stage 8 (R8) (the full maturity stage) (Zhang et al., 2017) when the color 
of the bean pods is green just before turning to yellow (Zeipi a et al., 2017). Young 
soybean has a large seed, tender, mild taste, and easily digestible. Moreover, it has a 
high protein content, lower oil content, and a low percentage of gas-producing starches 
(Zhang & Kyei-Boahen, 2007). Young soybean can be consumed by boiling the pods, 
adding beans to stews, with stir-fried vegetables (Zhang & Kyei-Boahen, 2007), and 
it can be used in making different products such as green noodles, green milk, and 
green tofu (Zeipi a et al., 2017). 
Young soybean is considered as a functional food and is known to have high 
nutritional and medicinal values similar to mature soybean (Zeipi a et al., 2017). It 
contains high protein content having contains all the essential amino acids. It is more 
digestible due to the lower trypsin inhibitor levels, compared to the mature soybean 
(Zhang et al., 2017). Young soybean also contains phosphorus, calcium, iron, vitamin 
E (Zeipi a et al., 2017), rich in isoflavones, ascorbic acid, and certain 
oligosaccharides, and low in niacin (Mentreddy et al., 2002).  
1.3.1 Compositions of young and mature soybean 
The young and mature soybean compositions can vary depending on the 
variety, the location, and the climate of planting (Chatterjee et al., 2018). Table 1 
shows the proximate composition of mature and young soybean from different studies. 




fiber of young and mature soybean that follows a conventional cropping practice. The 
moisture content in mature soybean that was reported by Redondo-Cuenca et al. 
(2007) was (9.82 g), which is slightly higher to moisture content values reported as 
8.59 g and 8.07 g by Güzeler and Y ld r m, (2016) and Etiosa et al. (2017), 
respectively. However, the moisture content of young soybean (10.81 g) (Redondo-
Cuenca et al., 2007) is very low than raw young soybean (67.5 g) (Ravishankar et al., 
2016). Redondo-Cuenca et al. (2007) reported the protein content in mature soybean 
to be (40.4 g). Mateos-Aparicio et al. 2008; Güzeler and Y ld r m, 2016 and Etiosa et 
al. 2017 have reported relatively similar protein content of mature soybean: (36 g, 36.5 
g, and 37.69 g), respectively. Redondo-Cuenca et al. (2007), reported the protein 
content in young soybean to be (37.1 g), while Ravishankar et al. (2016) have reported 
a lower protein content of 12.9 g for young soybean. Fat content in mature soybean is 
significantly higher than that of young soybean. Etiosa et al. (2017) has reported the 
fat content value in mature soybean to be (28.2 g). While relatively lower values of the 
fat content were reported by Redondo-Cuenca et al. (2007) 18.56 g, Mateos-Aparicio 
et al. (2008) 19 g, and by Güzeler and Y ld r m, (2016) 19.9 g. Young soybean has a 
lower fat content of 0.93 g reported by Redondo-Cuenca et al. (2007) and 6.8 g 
reported by (Ravishankar et al. (2016). The ash content in mature soybeans is higher 
as compared to the young soybeans. The reported values of ash in mature soybeans 
were 4.81 g, 4.9 g, and 4.29 g by (Redondo-Cuenca et al., 2007; G eler & Y ld r m, 
2016 and Etiosa et al., 2017), respectively. Young soybean has a lower ash content 
(3.39 g) (Redondo-Cuenca et al., 2007) and (1.7 g) (Ravishankar et al., 2016). The 
dietary fiber values of mature soybean were in the range of 16.5 g  17 g (Mateos-
Aparicio et al., 2008; Redondo-Cuenca et al., 2007). While, the fiber content reported 




al., 2017). Fiber content is lower in young soybean compared to mature soybean. 
Redondo-Cuenca et al. (2007) have reported a dietary fiber of 9.19 g, and Ravishankar 
et al. (2016), reported a crude fiber of 4.2 g in young soybean. Carbohydrates content 
also varies between the young and mature soybean crops with highest contents 
reported for mature soybean was 30.2 g (G eler & Y ld r m, 2016), followed by 30 g 
(Mateos-Aparicio et al., 2008), 16.31 g (Etiosa et al., 2017) and 9.94 g (Redondo-
Cuenca et al., 2007). Whereas the young soybean has a high carbohydrate content of 
38.6 g as reported by Redondo-Cuenca et al. (2007) and a very low content of 11 g 
was reported by Ravishankar et al. (2016).  
The two major proteins in soybean which account for 65  80 % and the 
precursor of the most isolated peptides are: glycinin and E- conglycinin (Singh et al., 
2014). Glycinin is composed of five subunits: G1, G2, G3, G4, and G5, whereas E- 
conglycinin has three subunits (D, Dc, and E) (Singh et al., 2014). Glycinin is not a 
conjugated protein and on the other hand, conglycinin is a glycoprotein that contains 
approximately 4% carbohydrates (predominantly mannose moieties). E- conglycinin 
is relatively resistant to hydrolysis even after removing its glycosylation sites (Isanga 
& Zhang, 2008). Partial hydrolysis of glycinin and E- conglycinin can result in the 
production of hydrolysates and peptides. The amino acid composition and sequence of 
these hydrolysates and peptides can be involved in biologically active functions such 
as anti-microbial, anti-diabetic, anti-oxidants, and anti-hypertensive activities (Agyei, 
2015). Furthermore, the minor proteins of the soybean are the lectin, Kunitz and 





Table 1: Proximate composition of mature and young soybean seeds (g/100 g). 
Soybean Moisture Protein Fat Fiber Carbohydrates Ash Reference 
Mature 
soybean 
9.82 40.4 18.56 16.5 9.94 4.81 
(Redondo-
Cuenca et al., 
2007) 
8.59 36.5 19.9 9.3 30.2 4.9 (Güzeler & Y ld r m, 2016) 
8.07 37.69 28.2 5.44 16.31 4.29 (Etiosa et al., 2017) 
 36 19 17 30  
(Mateos-
Aparicio et al., 
2008) 
8.43 37.29 17.86   4.99 (Ren et al., 2012) 
Young 
soybean 
10.81 37.1 0.93 9.19 38.6 3.39 
(Redondo-
Cuenca et al., 
2007) 
67.5 12.9 6.8 4.2 11 1.7 (Ravishankar et al., 2016) 
6.12 42.22 14.96   4.89 (Ren et al., 2012) 
 
1.3.2 Soybean protein hydrolysates production and their bioactive properties 
Bioactive peptides are specific protein fragments that can exert a positive effect 
on the human body and may influence health. These bioactive peptides are organic 
substances composed of amino acids that are joined covalently by peptide bonds 
(Sánchez & Vázquez, 2017) and can vary in terms of the number, type, and sequence 
of amino acids. 
1.3.2.1 Production of bioactive peptides 
Bioactive peptides can vary in their length of amino acids they possess and 
usually range from 2 to 20 amino acids. Different methods are used for the release of 




gastrointestinal digestion, enzymatic hydrolysis, food processing, and bacterial 
fermentation (Chatterjee et al., 2018). The enzymes that are used for in-vitro 
enzymatic hydrolysis or bacterial fermentation can influence the peptide production 
and its composition and the bioactive properties of the generated peptide is determined 
by the sequence of the amino acid and its composition when it releases from its 
precursor protein where it is encrypted (Chatterjee et al., 2018; Sánchez & Vázquez, 
2017). Bioactive peptides from protein sources can be obtained using any of the 
mentioned methods below. 
1.3.2.1.1 In-vitro simulated gastrointestinal digestion (SGID) 
The bioactive peptides can be generated upon digestion of the soybean proteins 
by application of gastric acid and digestive enzymes present in the stomach, small 
intestines, and pancreas like pepsin, chymotrypsin, trypsin, and pancreatin during the 
simulated conditions. The absorption of these peptides occurs through the walls of the 
small intestine and then to the bloodstream (Chatterjee et al., 2018). In such a model, 
simulated digestive juices from gastric and intestinal phase of digestion are formulated 
and used for digestion of protein samples. The generated hydrolysates are analyzed for 
identification of peptides by different advanced chromatographic techniques. 
1.3.2.1.2 In-vitro enzymatic hydrolysis 
Hydrolysis by enzymes is a common method to produce bioactive peptides by 
using single or multiple specific or nonspecific proteases (Rizzello et al., 2016). 
Enzymes require a short time to generate a similar degree of hydrolysis, and the 
enzymatic reaction can be controlled to produce a peptide with reproducible molecular 
weight profiles and compositions (Rizzello et al., 2016). Enzymatic hydrolysis is 




enzymes may be used in a combination to generate effective and stable bioactive 
peptide mixtures demonstrating a wide range of bioactive properties (Singh et al., 
2014). Range of food-grade enzymes are currently being employed for the generation 
of bioactive peptides of specific amino acid sequence. Different factors like pH, 
temperature, enzyme to substrate ratio is being taken into consideration to optimize 
the production of bioactive peptides using food-grade enzymes (Baba et al., 2021). 
1.3.2.1.3 Microbiological fermentation  
Another method for the production of bioactive peptides and food-grade 
hydrolyzed proteins is by implementing microbial fermentation. Fermentation can be 
done through either microbial activity or microbial enzymatic activity (Chatterjee et 
al., 2018). Lactic acid bacteria is a large group of bacteria that is found in the human 
digestive system and is widely spread in nature, is frequently used in producing 
bioactive peptides (Singh et al., 2014). It is important to use additional enzymes (e.g. 
trypsin and plasma proteases) when applying fermentation, since fermentation may not 
fully hydrolyze specific proteins for example soy proteins due to complex tertiary 
structure and the presence of post-translational modification (Chatterjee et al., 2018). 
Natto, kinema, and chungkookjang are soybean products produced by fermenting 
soybean with Bacillus only, while fermentation using fungi can produce another 
soybean product such as sufu, tempeh, douche (Sanjukta & Rai, 2016). It is important 
to choose suitable cultures, due to their effect on the type, amount, and activity of the 
peptides produced (Sánchez & Vázquez, 2017). The microbial fermentation by the 
action of proteolytic enzymes of mold and bacteria can ultimately improve the flavor 




1.3.2.2 Bioactive properties of soybean protein hydrolysates 
Researchers are focusing more on the so bean biologicall  acti e bioacti e  
peptides upon releasing from simulated gastrointestinal digestion (SGID), food 
processing, and enzymatic hydrolysis. Because these peptides have been proven to 
possess different bio-functional properties such as anti-hypertensive, anti-oxidative, 
anti-obesity, anti-diabetic, anti-inflammatory (AI), and anti-cancer properties 
(Chatterjee et al., 2018; Singh et al., 2014). Studies have demonstrated that partial 
hydrolysis of the predominant proteins which account for over 85% of total soy 
proteins: gl cinin and -conglycinin, can produce hydrolysates and peptides which 
provide the aforementioned bio-functional properties (Agyei, 2015). The range of 
bioactive properties demonstrated by soybean protein hydrolysates are summarized in 
the below mentioned sections. 
1.3.2.2.1 Antihypertensive properties 
Hypertension is considered to be a major risk factor for several diseases 
including brain stroke, renal and heart diseases. The effect of hypertension was 
estimated that one in six people or nearly one billion worldwide will be affected by it, 
and the number may increase by 2025 by 1.5 million (Chockalingam, 2007). The most 
common food-derived peptides are the antihypertensive peptides, and their activity is 
exhibited by inhibiting the angiotensin-converting enzyme (ACE) (De Mejia & Ben, 
2006). Several antihypertensive peptides have been derived from soybean and soybean 
products. Guan et al. (2018), have studied the enzymatic hydrolysis of soy protein 
isolates by corolase PP (food-grade porcine pancreatic proteolytic preparation) under 
high hydrostatic pressure conditions and estimated that the peptides generated under 




activity compared to the peptides generated at the atmospheric pressure (0.1 MPa). 
Okara  is a Japanese name for the so  pulp hich is a b -product of soybean curd 
tofu  production, has sho n an inhibition of ACE acti it  hen e amined in-vitro as 
a result of presence of antihypertensive peptides (Nishibori et al., 2017). A 
comparative study on ACE inhibition activity was conducted between two fermented 
tofus, the Japanese tofu and the Chinese sufu, and it was found that the Chinese sufu 
has higher inhibition of ACE activity than the Japanese tofu (Sanjukta & Rai, 2016). 
Another study was conducted to generate ACE inhibitory peptides from soy proteins 
by Lactobacilli fermentation. It was observed that Lactobacillus casei spp. 
Pseudoplantarum have exhibited higher proteolytic activity on the soy proteins and 
generated two peptides associated with ACE inhibition with IC50 values of 
approximately 17 and 30 µg/ml, respectively (Agyei, 2015). 
Coscueta et al. (2016) have reported that hydrolysates which have been 
generated from the enzymatic hydrolysis of soybean meal protein isolate with corolase 
PP at two different time and temperature conditions (70qC, 1 h; 90qC, 30 min) showed 
an ACE inhibitory activity. These hydrolysates have been characterized and detected 
and the main ACE inhibiting peptides identified were IRHFNEGDVLVIPPGVPY, 
IRHFNEGDVLVIPPGVPYW,IYNFREGDLIAVPTG, 
VSIIDTNSLENQLDQMPRR, and YRAELSEQDIFVIPAG (Coscueta et al., 2016).  
Hanafi et al. (2018), reported the ACE inhibitory activity of defatted green 
(young) soybean hydrolysates produced by different enzymes (alcalase, papain, 
flavourzyme, and bromelain). The highest ACE inhibitory activity was recorded for 
the hydrolysates generated by alcalase (IC50: 0.14 mg/ml at 6 h hydrolysis time), 
followed by the papain generated hydrolysates (IC50: 0.2 mg/ml at 5 h hydrolysis time), 




flavourzyme generated hydrolysates showed the least inhibitory activity (IC50: 1.14 
mg/ml at 6 h hydrolysis time). The peptides generated by alcalase that have exhibited 
the highest ACE inhibition were identified as EAQRLLF, PSLRSYLAE, 
PDRSIHGRQLAE, FITAFR, and RGQVLS with ACE-IC50 alues of 878 M, 532 
M, 1552 M, 1342 M and 993 M, respecti el . 
1.3.2.2.2 Antioxidative properties 
An excessive amount of the reactive oxygen species are considered hazardous 
and can lead to oxidative damage to the cell membranes and ultimately causes several 
different chronic diseases including diabetes, cancer, and cardiovascular diseases 
(Zhang et al., 2018b). The antioxidant compounds in the food industries and 
pharmaceuticals were greatly used to inhibit the effects of the reactive oxygen species 
and recently, a large interest in the use of protein hydrolysates and isolated peptides as 
a natural source of antioxidants is being explored (Zhang et al., 2018a). The bioactive 
peptides having antioxidant activities show a radical scavenging activity, chelating of 
metal ions, and inhibition of lipid peroxidation, and there are many peptides that are 
generally accepted antioxidants such as tyrosine, methionine, histidine, lysine, and 
tryptophan (Singh et al., 2014). 
A study was conducted to investigate the impact of the simulated 
gastrointestinal digestion, and the transepithelial transport on the antioxidant 
properties of soybean proteins hydrolyzed with alcalase (Zhang et al., 2018a). A wide 
variation was noticed in their antioxidant activities assessed using different assays such 
as 2,2 -diphenyl-1-picrylhydrazyl (DPPH) radical scavenging, 2,2 -azino-bis (3-
ethylbenzothiazoline-6-sulfonic acid) (ABTS) radical scavenging, ferric reducing 




to be 4.22, 2.93, and 0.67 mg/ ml, respectively. In addition, these hydrolysates have 
also inhibited the production of the intracellular reactive oxygen species in Caco-2 
cells. After the simulated gastrointestinal digestion, the hydrolysates shown enhanced 
antioxidant activities except for ABTS (Zhang et al., 2018a). Furthermore, Yang et al. 
(2000) have reported the antioxidative properties of the fermented soybean broth and 
found that the fermented soybean broth exhibit a scavenging activity on DPPH, on 
hydroxyl radicals, and on the peroxide anion radicals. Fermented soybean broth was 
able to chelate both ferrous and cupric ions. Jara et al. (2018) studied the release of 
antioxidant peptides from the soybean protein isolate by using a proteolytic extract 
prepared from a Maclura pomifera (plant-protease) latex. An IC50 of 31.6  0.2 g/ ml 
has been presented by the 90 min soybean hydrolysate. Hydrolysates demonstrated 
ABTS radical scavenging activity and oxygen radical absorbance capacity, to be 
157.6 and 176.9 moles Trolox equivalent per g of the peptide, respectively. The 90 
min antioxidant hydrolysates have been analyzed and identified fourteen theoretical 
peptides containing > 60% antioxidant amino acids. 
1.3.2.2.3 Antidiabetic properties 
Diabetes mellitus is a known common metabolic disorder and characterized by 
the dysregulation of blood glucose level. The major two forms are type 1 that is an 
insulin-dependent which makes up a 10%, of all diabetes cases, and type 2 the non-
insulin-dependent which makes up to 90%, of all diabetes cases (Wang et al., 2019). 
By 2035, the number of diabetic patients is projected to increase from 350 million 
today to 592 million (Lee et al., 2016). The triggering factors like obesity and 





Wang et al. (2019) have studied the different bioactivities of soybean protein 
hydrolysates including the antidiabetic properties. The hydrolysates were prepared 
ith three en mes: alkaline proteinase, papain, and tr psin. The highest -
glucosidase inhibition was exhibited by soybean protein hydrolysates generated with 
alkaline proteinase. The three novel -glucosidase inhibitory peptides that have been 
identified were: LLPLPVLK, SWLRL, and WLRL with IC50 of 237.43 ± 0.52, 182.05 
± 0.74, and 162.29 ± 0.74 mol/l, respectively (Wang et al., 2019). In another study, 
germinated soybean protein isolate was subjected to the gastrointestinal digestion to 
produce the bioactive peptides, which were demonstrated to act as an inhibitor of 
dipeptidyl peptidase IV (DPP-IV), -amylase (AA), and intestinal -glucosidases and 
modulated the postprandial glycaemic response (González-Montoya et al., 2018a). 
Peptide fractions of (5  10 kDa) and (> 10 kDa) were potentially inhibiting the DPP-
IV. On the other hand, the peptide fractions (5  10 kDa) and (<5kDa) were very 
effective in inhibiting the AA and -glucosidases (González-Montoya et al., 2018a). 
Several studies were conducted out on soy protein hydrolysates in the in-vivo 
model system to investigate their anti-diabetic properties. Jamilian & Asemi, (2015), 
studied the effect of soy intake on women with gestational diabetes mellitus and 
prepared a diet with soy protein which contains (35% animal protein, 35% soy protein, 
and 30% other plant proteins). The diet was consumed by a group of women aged 
between 18 - 40 years and at week 20  28 of gestation for 6 weeks (n = 34). The 
results have shown remarkable improvement on plasma glucose, serum insulin levels, 
and homeostasis model of assessment-insulin resistance as well as a decrease of the 
hospitalization and hyperbilirubinemia incidences of the newborns in the group 
consuming soy protein hydrolysate, when compared to the control group of women 




2015). It has been reported that aglycin is a natural bioactive peptide with 37 residues 
that is capable of resisting the proteolysis reactions during transit in the gastrointestinal 
system of mammals and can be found in plant albumins of pea seed including soybeans 
(Agyei, 2015). For example, Kehinde and Sharma, (2018) have reported the 
antidiabetic effects of aglycin in diabetic mice. Firstly, mice were fed with a fat-rich 
diet, followed by streptozotocin injection to induce diabetes. Aglycin was orally 
administered after dissolving it in saline solution (5 mg/ml) at a daily dosage (50 
mg/kg) for four weeks. The results showed significant control of hyperglycemia, an 
increase in glucose uptake, regulated glucose homeostasis, and restored insulin signal 
transduction. 
1.3.2.2.4 Miscellaneous bioactive properties of soybean peptides 
Many studies have investigated different bioactive properties of the soybean 
peptides such as the anticancer (González-Montoya et al., 2018b), hypocholesteremic 
(Ferreira et al., 2010), anti-inflammatory (Vernaza et al., 2012), inhibition of lipid 
accumulation (Martine Villaluenga et al., 2009). Table 2 shows different examples 
of bioactive properties of derived peptides and hydrolysates of soybean protein. 
Rayaprolu et al. (2013) have tested the bioactivity of high oleic acid soybean peptides 
against colon, liver, and lung cancer. High oleic acid soybean was hydrolyzed by 
alcalase to produce hydrolysates that were fractioned into different molecular sizes. 
Results showed that peptides inhibitory effect increases at higher concentrations and 
the peptides inhibited the cell growth of colon cancer by 73%, liver cancer by 70%, 
and lung cancer by 68% cells. On the other hand, González-Montoya et al. (2018b) 
studied the AI and anti-cancer activities of geminated soybean protein after subjecting 




pancreatin, followed by fractioning the peptides. The highest effect against AI and 
anti-cancer activities was obtained from the peptide fraction with a molecular weight 
between 5  10 kDa.  
Soy protein hydrolysates rich in E-conglycinin were also investigated for their 
effect on lipid accumulation mainly in 3T3-L1 adipocytes. Soy protein hydrolysates 
were produced from different genotypes by alcalase or gastrointestinal digestion on 
lipid accumulation in 3T3-L1 adipocytes. With (100 PM) soy hydrolysate generated 
by alcalase, lipid accumulation has reduced 33  37% inhibition by inhibiting the gene 
expressions of the lipoprotein lipase and fatty acid synthase. While with 100 PM of 
soy hydrolysate generated by SGID, it exhibited a lower lipid accumulation 8  14% 
inhibition through down regulating the gene expression of lipoprotein lipase 
(Martine Villaluenga et al., 2009).  
It has been observed that the main soy proteins E-conglycinin (7S) and glycinin 
(11S) were able to exert hypocholesterolemic effects when administrated at a dose of 
2.75%, daily by rats that have been fed with high cholesterol diet, and the results were 
comparable with fenofibrate a commercial drug (Ferreira et al., 2010). Lammi et al. 
(2015), reported three hypocholesteremic peptides from soy glycinin (IAVPGEVA, 
IAVPTGVA, and LPYP) that were used as a treatment on HepG2 cells, were able to 
modulate the cholesterol metabolism and interfere with the catalytic activity of 3-
hydroxy-3-methylglutaryl CoA reductase (HMGCoAR), which is a primary enzyme 




Table 2: Examples of soybean protein derived bioactive peptides and their different bioactive properties. 
Sample Enzyme Bioactive properties Hydrolysis conditions Peptide sequence identified Reference 
Defatted soy 
flakes 
Corolase PP Antihypertensive 
(5 h) hydrolysis time 
(80  300 MPa) 
LPDNAK, VQACSQEEVNK, 
ENFVYVAK, VLTTHTPPLK and 
GVAIMDFILR. 










(10 h) hydrolysis time 
(Alcalase, pH 8.0, 60°C; 
Bromelain, pH 6.5, 45°C; 
Flavourzyme, pH 8.0, 55°C; 
Papain, pH 6.5, 70°C). 
EAQRLLF, PSLRSYLAE, 
PDRSIHGRQLAE, FITAFR, and 
RGQVLS. 







Proteins isolated at (70°C, 1 h; 
90°C, 30 min) at (30 min to 24 
















Table 2: Examples of soybean protein derived bioactive peptides and their different bioactive properties (Continued). 








45°C for different hydrolysis 
times (10 180 min) 
 
Fourteen theoretical peptide sequences 
containing antioxidant amino acids at 
>60% 





Alcalase Antioxidant pH 8.5, 55°C for 3 h 
ALPEEVIQH, VIPPGVPY, VVPPGHPF, 
TILLPH, and NEPWWPK 









Antihypertensive - Leu-Val-Gln-Gly-Ser 









Gastric (37°C, 1 h) 
Intestinal (37°C, 2 h) 
Twelve peptides of different lengths from 
7 to 13 amino acids 
(González-








Table 2: Examples of soybean protein derived bioactive peptides and their different bioactive properties (Continued). 
Sample Enzyme Bioactive properties Hydrolysis conditions Peptide sequence identified Reference 
Soy protein 
isolate 
Alcalase Hypocholesterolemic DH 18% (pH 8.0, 60°C) WGAPSL 







Fatty acid synthase 
inhibitory peptides 
- 














Alkaline proteinase (pH 9, 
50°C) 
Papain (pH 6.5, 60°C) 
Trypsin (pH 7, 37°C). 
(For 8 h) 
Antidiabetic (D-glucosidase) 
LLPLPVLK, SWLRL, and WLRL 




- Hyporcholesteremic - IAVPGEVA, IAVPTGVA, and LPYP 





1.3.3 Characterization of soybean protein hydrolysates 
1.3.3.1 Degree of hydrolysis 
Degree of hydrolysis (DH) is the main parameter that monitors the extent of 
the protein hydrolysis when carried out by specific proteolytic enzymes (Nielsen et al., 
2001). The characterization of the protein hydrolysates which includes the 
determination of their degree of hydrolysis and their peptides distribution according to 
the chain length, is essential when developing new food products or dietary 
supplements (Morais et al., 2013). There are several methods for determining the 
degree of hydrolysis of proteins and each method has a different principle. The first 
principle is the determination of the hydrolytic release of nitrogen, where nitrogen 
becomes soluble in the presence of precipitating agents. The second principle is the 
determination of the free -amino-groups. The third principle is the titration of 
the protons that released upon cleavage of peptide bonds. The last principle is 
the measurement of the changes in the freezing point of the protein solution by 
osmometry (Morais et al., 2013).  
The parameters that are mostly used in the DH of soy protein hydrolysis are 
the average peptide chain length and the average molecular weight, and the DH 
reported for soy protein hydrolysates is usually between 1  39.5% (Sun, 2011). 
Hrckova et al. (2002), have indicated that the highest DH in soybean protein 
hydrolysates was 39.5% obtained by flavourzyme at 480 min. In addition, Wang et al. 
(2019) estimated the DH and the maximum degree after 8 h hydrolysis was (36.84%) 
using alkaline proteinase. Vallabha & Tiku, (2014) obtained a DH (22%) after the 
fermentation of the soy protein by lactic acid bacteria for 36 h. Coscueta et al. (2016) 
prepared the soy protein hydrolysates with corolase PP under two temperature 
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conditions (70qC, 1 h; 90qC, 30 min), and reached a maximum degree of hydrolysis 
18.9% and 20.4% at 70qC and 90qC, respectively at 10 h of hydrolysis. Corolase PP 
has been also used in preparing soy protein hydrolysates under high hydrostatic 
pressure, and the highest DH obtained was 30.6% at 4 h of hydrolysis and 200 MPa 
(Guan et al., 2018). Furthermore, the highest degree of hydrolysis in soy protein 
hydrolysates obtained using a proteolytic extract prepared from a Maclura pomifera 
(plant-protease) latex after 180-min (3 h) was 36.2% (Jara et al., 2018). These studies 
indicated that DH in soy protein hydrolysates varies and it depends on the type of 
enzymes used, condition of hydrolysis applied as well as composition of protein 
substrate. 
1.3.3.2 Electrophoretic techniques for separation of proteins 
Electrophoresis is defined as the movement and separation of charged ionic 
particles by the effect of an electric field. The mobility of the ionic particles is 
estimated according to the particle size, shape, charge, and temperature during the 
separation. Several types of separation by electrophoresis can be used such as 
polyacrylamide gel electrophoresis, isoelectric focusing, and capillary electrophoresis 
(Fritsch & Krause, 2003).  
Polyacrylamide gel electrophoresis (PAGE) method has been extensively used 
for the analysis of soybean proteins and their hydrolysates. PAGE combined with the 
ionic detergent sodium dodecyl sulfate (SDS) is applied to separate the protein 
subunits according to their size. In the characterization protocols, the sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) method is used to estimate 
the proteins composition of their subunits and their molecular mass (Smith, 2010). The 
SDS-desaturated proteins are separated mainly by sieving effects. For instance, the 
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lower molecular weight proteins will migrate faster through the gel, and to obtain a 
fairly accurate estimation, the migration rate of the sample protein can be compared to 
the standard proteins with a known molecular weight (Fritsch & Krause, 2003). 
For characterization of soybean-derived proteins and protein hydrolysates, 
Mujoo et al. (2003) analyzed the total protein profile for different varieties of soybean 
using SDS-PAGE and it was found that the protein bands were similar among all the 
arieties. -conglycinin (7S) subunits ere ( , , and ) ith molecular eight of 
around 80,000, 75,000, and 50,000, respectively. The acidic subunits of glycinin (11S) 
were found to have a molecular weight around 36,000 to 10,000, while the basic 
subunits were approximately 15,000. Jara et al. (2018) used the tricine-SDS-PAGE to 
separate the hydrolysates of the soybean protein isolate into their molecular masses. 
The  obtained se eral -congl cinin subunits ( , , and ) ith molecular masses 
between 47 and 67 kDa. Moreover, the acidic and basic subunits of glycinin with 
molecular masses of 36 and 22 kDa, respectively were also reported. Coscueta et al. 
(2016) have also used the tricine-SDS-PAGE to characterize the soybean protein 
hydrolysates of different molecular weight profiles. The gel electrophoresis clearly 
displa ed separate bands for subunits for gl cinin and -conglycinin for both soybean 
hydrolysates, which were prepared at 70°C for 1 h and 90°C for 30 min. For soybean 
protein hydrolysate produced at 70°C (SPH70), glycinin subunits were intact until 4 
h, hile -conglycinin bands were hydrolyzed and nearly disappeared at 4 h. Glycinin 
subunits of soybean hydrolysate produced at 90°C (SPH90) remained intact and nearly 
disappeared at 4 h, and -conglycinin bands started to disappear at 30 min. Besides, 
the author has reported that the hydrolysates SPH70 and SPH90 have revealed new 
bands at 25 kDa and below 20 kDa up to small peptides at the bottom of the gel 
(Coscueta et al., 2016).  
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Furthermore, Hrckova et al. (2002) investigated the effect of the hydrolysis of 
soybean proteins by different enzymes by using SDS-PAGE. It was noticed that the 
gl cinin consist of acidic and basic subunits and -congl cinin subunits ( , , and ). 
The protein hydrolysates were subjected to breakdown by all the enzymes used 
(novozyme, flavourzyme, and alcalase), and ultimately the low molecular weight 
proteins have concentrated only at the bottom of the gel. Glycinin exhibits higher 
resistance to the en matic h drol sis, hereas -conglycinin degrades easily. The 
basic glycinin fraction breaks down slower than the acidic glycinin fraction, which 
could be due to the fact that the basic glycinin peptides tend to form large complexes 
and thus becomes less subjected to the enzymatic hydrolysis (Hrckova et al., 2002). 
1.3.3.3 Chromatographic techniques 
Chromatographic techniques which are based on partitioning or distribution of 
sample molecules between the mobile phase and stationary phases have been applied 
to separate different organic components. The fixed or stationary phase can be liquid, 
or frequently a solid, while the moving or mobile phase can be a gas, liquid, or 
supercritical fluid. Chromatographic techniques are further divided into the different 
techniques applied, such as gas chromatography, liquid chromatography, paper 
chromatography, and column liquid chromatography (Ismail & Nielsen, 2010). The 
high-performance liquid chromatography (HPLC) method is now being used 
extensively for analyzing protein hydrolysates and peptides due to the effective 
separation, versatility, better resolution, speed (short times for analysis), and suits the 
automation procedures (de Llano & Sánchez, 2003). Chromatographic separation of 
peptides based on the molecule size (gel permeation chromatography), charge (ion-
exchange chromatography), hydrophobicity (reversed-phase and interaction 
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chromatography), and with combinations of all these methods (de Llano & Sánchez, 
2003) is being used for characterizing protein hydrolysates and peptides. 
Reversed-phase high-performance liquid chromatography (RP-HPLC) is 
widely used for separating peptides according to their hydrophobic properties 
(Rizzello et al., 2016). Reversed-phase columns that are employed for the separation 
of small peptides are with pore sizes of 6  10 nm. Large peptides with molecular 
weights of 4000 kDa are recommended to be separated using a column with pore sizes 
of 30-50 nm (de Llano & Sánchez, 2003). RP-HPLC has been largely used for the 
analysis of plant proteins (Reuhs & Rounds, 2010). An example of a study where five 
steps of purification procedures were conducted to produce a novel ACE-inhibitory 
peptide from fermented soybean extract. The purification procedure involved 
ultrafiltration and other consecutive chromatographic methods, which included the 
RP-HPLC, cation exchange chromatography, and gel permeation chromatography. 
The author reported that the novel ACE-inhibitory peptide which was separated 
showed a 66-fold inhibitory activity as compared to the fermented soybean extract 
(Rho et al., 2009). 
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Chapter 2: Methods 
 
2.1 Enzymes and reagents 
Alcalase from Bacillus licheniformis (EC 3.4.21.62), bromelain from 
pineapple stem (EC 3.4.22.32), flavourzyme from Aspergillus oryzae (EC 232-752-2), 
pepsin from gastric mucosa (EC 3.4.23.1), pancreatin from porcine pancreas (EC 232-
468-9), -amylase from porcine pancreas (EC 3.2.1.1), DPP-IV human (EC 3.4.14.5), 
porcine pancreatic lipase (EC 3.1.1.3), cholesterol esterase enzyme from 
porcine pancreas, (EC 3.1.1.13) were purchased from Sigma-Aldrich Chemical 
Company (St. Louis, MO, U.S.A). 
Reagents like petroleum ether, sulfuric acid, Kjeldahl catalyst, bile salts 
(Oxgall), Folin-Ciocalteu reagent, gallic acid, 6-hydroxy-2,5,7,8-tetramethylchroman-
2-carboxylic acid (Trolox), o-phthaldialdehyde (OPA), 2,2 -azino-bis (3-
ethylbenzthiazoline-6-sulfonic acid) (ABTS), 2,2 -diphenyl-1-picrylhydrazyl 
(DPPH), p-nitrophenyl- -D-maltohexaoside (pNPM), monosodium phosphate 
monobasic, disodium phosphate dibasic, Gly-Pro-p- nitroanilide, Trizma base, 
Acarbose, Diprotin (Ile-Pro-Ile), p-nitrophenyl butyrate, Orlistat, sodium acetate, 
2,4,6-tripyridyl-s-triazine (TPTZ), ferric chloride hexahydrate, potassium persulphate, 
methanol, ethanol, hexane, sodium hydroxide, sodium dodecyl sulphate (SDS), 
sodium tetraborate, -mercaptoethanol were all purchased from BDH middle east or 
Sigma-Aldrich Chemical Company (St. Louis, MO, U.S.A).  
2.2 Sample preparation 
Mature soybean (MS) seeds were procured from the local supermarket of Al 
Ain, Abu Dhabi, United Arab Emirates (UAE). Young soybean (YS) seed powder was 
procured from Kimuraya Company, Japan. The dried MS seeds were crushed using a 
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commercial mixer grinder (Moulinex, France) and sieved through a mesh (20 µm) to 
obtain a fine powder. The resultant powders of MS and YS were stored at -20  under 
airtight conditions until used. 
2.3 Proximate composition analysis  
The proximate composition of YS and MS was estimated using the standard 
procedures of Association of Official Analytical methods (AOAC, 2000). Moisture 
content was estimated by hot air oven method at 70°C for three days. Fat content was 
determined by Soxhlet apparatus using petroleum ether as an organic solvent at 80°C 
for 1 h. Total protein content was analyzed by Kjeldahl method and ash content was 
determined by weighing the amount of residues present after burning the samples in 
the muffle furnace at 550°C for 18  24 h. Carbohydrate content was then estimated 
using subtraction method. 
2.4 Phase 1: Analysis of bioactive properties of young and mature soybean 
subjected to simulated gastrointestinal digestion (SGID) 
2.4.1 In-vitro simulated gastrointestinal (SGID) of young and mature soybean 
powder 
A static model that simulates digestion in stomach and intestine was adopted 
according to a method as described by Ahmad et al. (2019), involving, simulated 
gastric juice (SGJ) for gastric digestion and simulated intestinal juice (SIJ) to mimic 
intestinal digestion. Briefly, SGJ was prepared by addition of 3 g/l of pepsin and 
sodium chloride (NaCl) 9 g/l in sterile deionized water and the pH was adjusted to 2.0 
using 1.0 mol/l hydrochloric acid (HCl). Similarly, SIJ was prepared by mixing 10 g/l 
bile salts (Oxgall) and 3 g/l of pancreatin in sterile phosphate-buffered saline and the 
pH was adjusted to 8.0 with 0.1 M NaOH solution. To proceed with simulated 
gastrointestinal digestion (SGID), 5 g of YS and MS powdered samples were 
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individually mixed with 50 ml of SGJ and incubated for 2 h to digest the samples under 
simulated gastric conditions. Thereafter, an aliquot of 20 ml from each sample was 
taken to represent the gastric digested sample (SGD) and to the remaining portion, 50 
ml of SIJ was added and incubation was performed at 37°C for 3 h under constant 
stirring to obtain a complete SGID sample. The obtained samples were then heated at 
100°C for 10 min to stop the enzymatic reaction and centrifuged at 10,000 × g for 10 
min at 4 . All the supernatants (SGD and SGID) thus obtained ere stored at -20°C 
until further analysis which was carried out within one month. 
2.4.2 Total phenolic content (TPC) 
The total phenolic contents of the digested YS and MS samples were 
determined using Folin-Ciocalteu assay (El Sohaimy, 2013). Briefly, 0.5 ml of the 
digested soybean samples were mixed with 2.5 ml of Folin-Ciocalteu reagent followed 
by addition of 2 ml of sodium carbonate (Na2CO3) (75 g/l). The mixtures were then 
incubated for 5 min at 50qC, 200 Pl volume was transferred to a 96 well microplate 
and the absorbance of the samples was measured at 760 nm a microplate reader (Epoch 
2, BioTek, VT, USA), and the phenolic content was expressed as mg gallic acid 
equivalents per gram of soybean (mg GAE/g). 
2.4.3 Inhibition of key enzymes related to diabetes  
2.4.3.1 Inhibition of -amylase (AA) 
The AA inhibition was evaluated for the digested samples of YS and MS as 
described by Mudgil et al. (2019c). Approximately, 25 Pl of the samples were mixed 
with 50 Pl of p-nitrophenyl- -D-maltohexaoside (pNPM; 5mM) (substrate) and 50 Pl 
of porcine pancreatic AA enzyme (5 mg/ml) in 96-well microplate. The total reaction 
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volume was set at 250 Pl using sodium phosphate buffer (0.02 M; pH 6.9) and 
incubated at 37°C for 90 min. A control reaction (without soybean samples) was 
included and prepared in a similar way to represent a 100% enzyme activity. The 
absorbance of the produced p-nitrophenyl was measured at 405 nm on a microplate 
reader (Epoch 2, BioTek, VT, USA). To eliminate the background absorbance 
produced from samples blank reactions (samples with substrate and buffer without 
enzyme) were conducted for each sample. Acarbose was used as a positive inhibition 
control. Each sample was analyzed in triplicate and the percentage of AA inhibition 
was calculated using equation-  




where A (control), B (control blank), C (sample), and D (sample blank) refer 
to the absorbance values of reaction vials containing enzyme and buffer, No enzyme 
only buffer, enzyme and sample, and No enzyme only sample, respectively. Substrate 
was present in all reactions.  
The inhibitory concentration values that inhibit 50% (IC50) of AA activity were 
measured by plotting the percentage inhibition as a function of the test compound 
concentration. The IC50 values were expressed as g of phenolic equi alent/ml.  
2.4.3.2 Inhibition of dipeptidyl peptidase IV (DPP-IV) 
The inhibitory activity of DPP-IV was determined as described by Kamal et 
al. (2018) for the YS and MS. Soybean samples (25 Pl) were added to 50 Pl of the 
reaction substrate Gly-Pro-p- nitroanilide (0.5 mM), 25 Pl of DPP-IV (8 U/ l), 100 Pl 
of 0.1 M of TRIS-HCl buffer (pH 8.0) and the mixture was incubated at 37°C for 90 
min. The absorbance of p-nitroanilide released was measured at 405 nm using the 
microplate reader (Epoch 2, BioTek, VT, USA). A control reaction (without soybean 
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samples) was included and prepared in a similar way to represent a 100% enzyme 
activity. Blank reactions were also prepared as described above in Section 2.4.3.1. 
Diprotin (Ile-Pro-Ile), was used as a positive inhibition control. The percentage of 
DPP-IV inhibitory activity was measured using the equation as described above in 
Section 3.4.3.1. The inhibitory concentration values that inhibit 50% (IC50) of DPP-IV 
activity were measured by plotting the percentage inhibition as a function of the test 
compound concentration. The IC50 values were expressed as g of phenolic 
equivalent/ml. 
2.4.4 Inhibition of key enzymes related to obesity  
2.4.4.1 Inhibition of pancreatic lipase (LIP) 
The LIP inhibitory activity assay was estimated according to method 
conducted by Ahmad et al. (2019). Briefly, samples (25 Pl) were mixed with 25 Pl of 
pancreatic LIP solution (5 mg/ml), 50 Pl of p-nitrophenyl butyrate (5 mM) as substrate, 
and sodium phosphate buffer (0.1 M, pH 7.2) in a 96-well microplate and incubated at 
37°C for 90 min. A control reaction (without soybean samples) was included and 
prepared in a similar way to represent a 100% enzyme activity. The absorbance of the 
released p-nitrophenyl was monitored at 405 nm in a microplate reader (Epoch 2, 
BioTek, VT, USA). Blank reactions were also prepared as described above in Section 
3.4.4.1. Orlistat was used as positive inhibition reaction control and the percentage of 
LIP inhibition was measured using the similar equation as described in Section 2.4.3.1. 
The inhibitory concentration values that inhibit 50% (IC50) of LIP activity were 
measured by plotting the percentage inhibition as a function of the test compound 
concentration. The IC50 alues ere e pressed as g of phenolic equi alent/ml. 
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2.4.4.2 Inhibition of cholesterol esterase (CE) 
The CE inhibition was determined using a method described by Mudgil et al. 
(2019b). Briefly, in a 96-well microplate, 25 l of test samples, 50 l of substrate 
containing 5 mM p-nitrophenyl butyrate in 100 mM sodium phosphate buffer and 100 
mM NaCl (pH 7.2) ere incubated ith 50 l of porcine pancreatic CE (5 g/ml) at 
37°C for 30 min. The released p-nitrophenol upon the enzymatic hydrolysis of p-
nitrophenyl butyrate was measured at 405 nm on the microplate reader. Orlistat was 
used as positive inhibition control and the percentage of the inhibitory activity against 
CE was calculated using the equation described in Section 2.4.3.1. The inhibitory 
concentration values that inhibit 50% (IC50) of CE activity were measured by plotting 
the percentage inhibition as a function of the test compound concentration. The IC50 
alues ere e pressed as g of phenolic equi alent/ml. 
2.4.5 Antioxidant activities 
2.4.5.1 Ferric reducing/antioxidant power (FRAP) assay 
The ferric reducing ability of MS and YS upon SGID was evaluated using the 
ferric reducing/antioxidant power (FRAP) as described by Benzie and Strain, (1996) 
and further modified by Al-Shamsi et al. (2018). Working solution of FRAP reagent 
was prepared by addition of sodium acetate buffer (300 mM; pH 3.6), FeCl3.6H2O 
(20 mM) and 2,4,6-tripyridyl-s-triazine (TPTZ; 10 mM prepared in 40 mM HCl) in a 
ratio of 10:1:1 v/v. The FRAP assay was carried out in 96 well microplate where, 10 
l of test samples ere mi ed ith 200 l of the freshly prepared FRAP reagent and 
the incubation as carried out at 37  for 30 min in the dark. The absorbance of the 
resultant blue product (ferrous tripyridyltriazine complex) was read at 593 nm in a 
microplate reader (Epoch 2, BioTek, VT, USA). For sample blank preparation FRAP 
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reagent devoid of FeCl3.6H2O was used instead. A standard curve of Trolox ranging 
from 50  600 M as prepared and ere the FRAP po er of samples as e pressed 
as Trolox equivalent antioxidant activity (TEAC) g of phenolic equivalent/ ml.  
2.4.5.2 2,2 -azino-bis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) radical 
scavenging assay 
The antioxidant activity (scavenging of the ABTS radical) was measured as 
according to Al-Shamsi et al. (2018). The stock solutions used in the essay were 7.4 
mM ABTS solution and 2.6 mM potassium persulphate solution. To prepare the 
working solution, an equal quantities of the two stock solutions were mixed and left to 
react for 12 h in the dark at room temperature to generate ABTS radicals. 
Appro imatel , 20 l of sample with a concentration range of 0.5 10 mg/l was mixed 
ith 180 l of ABTS solution and made to stand for 30 min at room temperature in 
dark. The absorbance was then read at 734 nm the microplate reader (Epoch 2, BioTek, 
VT, USA). A sample blank at each concentration was prepared in the same manner 
except that methanol was used instead of ABTS solution. A standard curve using 
Trolo  ranging from 50 to 600 M as made and the acti it  as e pressed as Trolox 
equi alent antio idant acti it  (TEAC) g of phenolic equi alent/ ml. 
2.4.6 Anti-inflammatory (AI) activities 
AI activity was conducted according to the method described by Kamal et al. 
(2018). Briefly, in a 96-well microplate, the reaction mixture was prepared by mixing 
100 l of sample, 50 l of egg albumin (from fresh hen egg), and 100 l of phosphate 
buffer saline (PBS) (pH 6.4). The control was prepared by replacing sample volume 
with same amount of PBS with distilled water. Incubation of the reaction mixture was 
set at 37°C for 15 min and then heated at 70°C for 5 min to terminate the reaction. The 
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absorbance of the reaction mixture was measured at 600 nm in a microplate reader 
(Epoch 2, BioTek, VT, USA). The standard curve was prepared with diclofenac 
sodium at a final concentration of 100 to 2,500 g/ml that was used as a reference 
drug. The results were expressed as Diclofenac sodium equivalent capacity (DSEC) of 
g phenolic equivalent/ ml. 
2.5 Phase 2: Analysis of bioactive properties of young and mature soybean protein 
hydrolysates upon enzymatic hydrolysis 
2.5.1 Isolation of proteins 
YS and MS proteins were isolated according to a method described by Aluko 
and Monu, (2003) and modified by Mudgil et al. (2019d). The YS and MS seeds were 
initiall  grinded and then sie ed through a sie e (3 m pore si e) to obtain a fine 
powder as described earlier in Section 2.2. Then, YS and MS flours (YS = 500 g, MS 
= 1000 g) were defatted in hexane for 2 h and centrifuged at (4255 × g, 15 min, 4°C). 
After centrifugation, deionized water was added at a ratio of 1:5 w/v, and the pH was 
adjusted to (10 11) with 20% NaOH to facilitate solubilization of proteins. The 
mixtures thus obtained were stirred at 400 rpm for 4 h at room temperature (24 ± 2°C) 
and the obtained slurries were then stored overnight at 4°C to promote better separation 
of proteins. The slurries were then homogenized using IKA ultra turrax T25 basic 
homogenizer at 15,000 rpm for 5 min and centrifuged two times at 4700 × g for 15 
min at 4°C and then again at 10,000 × g for 15 min at 4°C. The resultant supernatants 
were collected and filtered through Whatman no. 1 filter paper to remove any 
remaining fat. Proteins were then precipitated using pH drop method, for which pH 
was lowered to 4.0 using 6M HCl. The precipitated proteins were then separated by 
centrifugation at 10,000 × g; 10 min, 4°C and washed twice using a deionized water. 
The obtained pellets ere neutrali ed using 1.0 M NaOH to pH 7.0, stored at 20 C 
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and then freeze dried using LyoAlfa freeze dryer (Telstar, Barcelona, Spain). The 
protein content of YS and MS was determined according to the Kjeldahl method 
(Kjeldahl, 1883), and their values are displayed in Table 3.  
 
Table 3: Protein content of young and mature soybean seeds and their protein 
isolates (%). 
Protein content Seed (%) Protein isolate (%) 
Young soybean 36.62 68.85 
Mature soybean 41.38 75.71 
 
 
2.5.2 Production of protein hydrolysates  
The freeze dried soybean protein concentrates were subjected to hydrolysis 
using different proteolytic enzymes (alcalase, bromelain and flavourzyme) as 
described by Aluko and Monu, (2003) and modified by Mudgil et al. (2019d). First, 
the YS and MS protein concentrates were dispersed in distilled water to a protein 
content of 4% v /v and the pH was adjusted to (7.0). YS and MS proteins were then 
divided into three equal proportions in Schott bottle for the enzymatic hydrolysis using 
the three different enzymes in triplicate as per the plan depicted in Table 4. A portion 
of 60 ml of each YS and MS protein was kept separately to be used as control. Then, 
the pH was adjusted for both soybeans slurries to (pH 8.0 for alcalase and pH 7.0 for 
bromelain and flavourzyme) and monitored by a digital pH meter (Starter 3100, Ohaus, 
Parsippany, NJ). Enzyme: substrate (E:S) ratio at 1:100 was prepared by dissolving a 
pre-calculated amount of enzymes in 1 ml of deionized water and then added to their 
particular YS or MS protein concentrates. Temperature-controlled water bath was used 
to carry out the enzymatic hydrolysis at 50°C, at speed of 100 ramps/min for 6 h. YS 
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and MS hydrolysates were taken after every 2 h of incubation, and the enzymes were 
deactivated by heating the hydrolysate samples at 100°C for 5 mins and cooled down 
immediately in ice bath. Hydrolysate samples were centrifuged at 10,000 × g, 5 min, 
4°C, and the protein content was determined using bicinchoninic acid assay and 
resultant supernatants were stored at -20°C for further analysis. 
 
Table 4: Hydrolysis conditions for producing the young and mature soybean 
hydrolysates. 
Enzyme Enzyme: Substrate ratio pH Time (h) Temperature (°C) 
Alcalase 1:100 8.0 2, 4, 6 50 - 60°C 
Bromelain 1:100 7.0 2, 4, 6 50°C 
Flavourzyme 1:100 7.0 2, 4, 6 50 - 55°C 
 
2.5.3 Characterization of young and mature soybean protein hydrolysates upon 
enzymatic hydrolysis  
2.5.3.1 Degree of hydrolysis 
Degree of hydrolysis (DH) was analyzed using the o-phthaldialdehyde (OPA) 
method as described by Church et al. (1983) and modified by Jafar et al. (2018). To 
prepare OPA reagent, 40 mg of OPA was dissolved in 1 ml of methanol and then mixed 
with 2.5 ml of sodium dodecyl sulphate (SDS) (20% w/w), 25 ml of 100 mM sodium 
tetraborate buffer (pH 9.3), and 100 l of -mercaptoethanol. Milli Q water was then 
used to raise the final volume to 50 ml. Hydrolysate samples (20 l) were added to 200 
l of OPA reagent in a 96-well plate. After 1 h of incubation at room temperature in 
the dark, the absorbance was monitored at 340 nm in a microplate reader (Epoch 2, 
BioTek, VT, USA). The free amino nitrogen (FAN) content was determined using a 
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standard curve of tryptone and % DH was determined by using equation below, where 
unhydrolysed MS and YS were used as control samples.  
𝐷𝐻%
𝐹𝐴𝑁 𝐹𝐴𝑁  
𝐹𝐴𝑁  
  100 
2.5.4 Inhibition of key enzymes related to diabetes and obesity 
Enzyme inhibitory assays were carried out as described in Sections 2.4.3 and 
2.4.4 above. The half-maximal inhibitory concentration (IC50) values were determined 
by plotting the percentage inhibition as a function of the test compound concentration 
expressed in g of protein equivalents/ ml.  
2.5.5 Antioxidant activities 
2.5.5.1 2,2’-diphenyl-1-picrylhydrazyl (DPPH) scavenging assay 
DPPH radical-scavenging activity was determined by DPPH assay as 
described by Al-Shamsi et al. (2018). Briefl , samples (100 l) were diluted with 100 
l of 0.15 mM 2,2 -diphenyl-1-picrylhydrazyl (DPPH) in 95% ethanol. The mixture 
was shaken and made to stand at room temperature for 30 min in the dark. The 
absorbance was monitored at 517 nm using the microplate reader (Epoch 2, BioTek, 
VT, USA). (The preparation of the blank was done in the same manner except that the 
distilled water was used instead of the sample) Preparation of standard curve of Trolox 
was made in the range of 10 60 M and the acti it . The results were expressed as 
Trolox equivalent antioxidant acti it  (TEAC) g of protein equi alent/ ml.  
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2.5.5.2 FRAP and ABTS antioxidant activities  
The FRAP and ABTS assays were performed as described in Section 2.4.5 
above and their values were expressed as Trolox equivalent antioxidant activity 
(TEAC) g of protein equivalent/ ml. 
2.5.6 Anti-inflammatory (AI) activities 
The AI activities performed as described in Section 2.4.6 above. The results 
were expressed as Diclofenac sodium equivalent capacity (DSEC) of g protein 
equivalent/ ml. 
2.6 Statistical analysis 
All experiments were carried out in three independent replicates and each 
replicate was analyzed twice. To determine statistically significant differences 
between the samples (P<0.05), the data were subjected to Analysis of Variance 
(ANOVA) and appropriate means separation as conducted using Tuke s multiple 
range test using a statistical software program (SPSS version 25 for Windows, 2012, 
Chicago, IL, USA). 
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Chapter 3: Results 
 
3.1 Proximate composition 
The proximate composition of YS and MS flour has been expressed in g/ 100g. 
As shown in Figure 1, moisture content was higher in YS (7.28 + 0.17 g/ 100g) than 
MS (5.71 ± 0.17 g/ 100g). Ash content was slightly higher in MS (5.28 ± 0.05 g/ 100g) 
than YS (4.67 ± 0.02 g/ 100g). Similarly, fat content was slightly higher in MS than 
YS with values of 15.91 ± 1.56 g/ 100g and 15.004 ± 0.22, respectively. Moreover, 
MS contained a higher content of protein (41.38 ± 0.006 g/ 100g) compared to the YS 
(36.58 ± 0.006 g/ 100g). However, YS showed high carbohydrate value than MS with 
values of 36.46 g/ 100g and 31.72 g/ 100g, respectively. 
 
 
Figure 1: Proximate composition of young and mature soybean. Values are 




3.2 Phase 1: Effect of simulated gastrointestinal digestion (SGID) on total 
phenolic content and bioactive properties of young and mature soybeans 
3.2.1 Total phenolic compounds (TPC) 
The results of the total phenolic content (TPC) which are expressed as gallic 
acid equivalent (µg GAE /ml) are presented in Figure 2. TPC was analysed for YS and 
MS samples after simulated gastric and intestinal stages. The results showed that all 
of the samples of YS and MS contained phenolic compounds and their concentrations 
increased after the samples were subjected to gastrointestinal phase (SGID). TPC 
increased after the gastric and the SGID phase of digestion in both YS and MS. YS 
samples displayed a higher concentration of TPC when compared to MS, except that 
for the control sample of YS before SGID (55.66 ± 13.83 µg GAE /ml) which showed 
less concentration than control (before SGID) of MS (176.05 ± 15.96 µg GAE /ml). 
TPC of YS has increased significantly after subjecting the sample to gastric and SGID 
phases of digestion when compared to the control sample. After complete SGID 
treatment, YS showed the highest TPC (689.27 ± 12.06 µg GAE /ml), followed by YS 
subjected to gastric phase (300.10 ± 19.35 µg GAE /ml), and the control YS samples 
(55.66 ± 13.83 µg GAE /ml). Similar observations were found for MS. TPC of MS 
increased significantly after subjecting it to gastric digestion and SGID (211.47 ± 
63.95 and 376.98 ± 42.76 µg GAE /ml) compared to the control sample (176.05 ± 




Figure 2: Total phenolic content of young and mature soybean after simulated gastric 
and gastrointestinal digestion (SGID). Data is presented as µg of gallic acid 
equivalent/mg of ml of sample (µg GAE /ml). Different small letters on each bar 
indicates significant difference between different samples analysed. Keynotes: YS-
young soybean, MS-mature soybean. 
 
3.2.2 Inhibition of key enzymes related to diabetes by young and mature soybean 
subject to SGID 
3.2.2.1 D-amylase (AA) inhibitory activity 
The AA inhibitory activity of YS and MS samples subjected to simulated 
gastric and gastrointestinal digestion (SGID) is depicted in Figure 3 and is represented 
in AA inhibitory-IC50 (µg/ml). As indicated, all samples of YS and MS inhibited the 
AA enzyme effectively compared to control soybean samples (before SGID). Overall, 
the strongest inhibitory activity of AA was shown by MS at gastric digestion (IC50: 
25.95 ± 0.84 µg/ml) while the lowest was shown by the control samples of MS and 
YS (IC50: 35.01 ± 0.47 and 34.85 ± 2.3 µg/ml, respectively). For YS, the highest 
inhibition of AA enzyme was display after the gastric digestion phase (IC50: 28.23 ± 
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IC50 values of 34.85 ± 2.3 µg/ml and 30.83 ± 2.23 µg/ml, respectively. Furthermore, a 
similar observation was shown by MS extract, where gastric digested samples showed 
higher inhibition compared to control and complete SGID samples. Overall, gastric 
digested MS showed the highest AA inhibition with an IC50 value of 25.95 ± 0.84 
µg/ml, followed samples subjected to complete SGID (IC50 value 30.1 ± 1.08 µg/ml) 
and control sample (IC50: 34.85 ± 2.3 µg/ml). MS and YS showed an insignificant 
difference of AA enzyme inhibition for control and SGID samples, and a significant 
difference was observed for the gastric digested samples where MS was slightly lower 
(P<0.05) in the IC50 value compared to YS. 
 
 
Figure 3: AA inhibition of young and mature soybean upon subjecting to gastric and 
gastrointestinal digestions (SGID). Values are represented in IC50 (µg/ml). Different 
small letters on each bar indicates significant difference between different samples 
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3.2.2.2 Dipeptidyl peptidase IV (DPP-IV) inhibitory activity 
The ability of YS and MS subjected to simulated gastric and SGID treatments 
to inhibit the DPP-IV enzyme is shown in Figure 4. YS and MS samples were able to 
inhibit DPP-IV activity at different levels when subject to SGID. In general, YS and 
MS after simulated gastric digestion exhibited the highest DPP-IV inhibition with a 
DPP-IV inhibitory IC50 value of 22.34 ± 0.28 and 22.7 ± 0.85 µg/ml, respectively 




Figure 4: DPP-IV inhibition of young and mature soybean upon subjecting to gastric 
and gastrointestinal digestions (SGID. Values are represented in IC50 (µg/ml). 
Different small letters on each bar indicates significant difference between different 
samples analysed. Keynotes: YS-young soybean, MS-mature soybean. 
 
Thus, in case of YS, the simulated gastric digested samples showed the highest 
DPP-IV inhibition with an IC50 value of 22.34 ± 0.28 µg/ml, followed by the control 
YS samples with DPP-IV inhibitory IC50 value of 28.56 ± 0.64 µg/ml, and those 
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subjected to complete SGID with DPP-IV inhibitory IC50: 33.45 ± 0.69 µg/ml. A 
similar pattern was observed for the MS samples, where the sample at gastric digestion 
showed the highest inhibitory activity, then the control sample and the least inhibitory 
activity was shown by the sample subjected to complete SGID with IC50 values of 22.7 
± 0.85 µg/ml, 27.08 ± 1.16 µg/ml, and 33.43 ± 1.79 µg/ml, respectively. Overall, the 
differences between the YS and MS samples when subjected to gastric, SGID, and the 
control were insignificant (P>0.05). 
3.2.3 Inhibition of key enzymes related to obesity by young and mature soybean 
subject to SGID 
3.2.3.1 Pancreatic lipase (LIP) inhibitory activity 
LIP inhibitory activity of the simulated gastric digested and SGID samples 
from YS and MS is shown in Figure 5. As can be seen from the figure, all YS and MS 
samples have exhibited LIP inhibitory activities with IC50 values ranging from 88.68 
± 8.66 to 36.94 ± 1.84 µg/ml. The highest inhibitory activity of the LIP enzyme was 
observed by the gastric digested YS (36.94 ± 1.84 µg/ml) and the least inhibition was 
presented by the YS control samples sample (IC50: 88.68 ± 8.66 µg/ml). YS displayed 
significant increase in the LIP inhibition upon gastric digestion (IC50: 36.94 ± 1.84 
µg/ml) and complete SGID (IC50: 46.94 ± 1.63 µg/ml). On the other hand, MS 
displayed no change in inhibition of LIP when the samples were subjected to simulated 
gastric digestion and to the inhibition displayed by control sample (P>0.05). The 
control of MS showed LIP inhibitory IC50 value of 45.53 ± 1.66 µg/ml, and IC50 of the 
gastric digested samples was 43.36 ± 0.31 µg/ml, and SGID treated MS possessed an 
IC50 value of 46.54 ± 3.05 µg/ml. In general, the IC50 value of YS control sample was 
significantly higher than MS control sample, and the gastric digested sample of YS 
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was significantly lower than the IC50 value of MS. However, the IC50 values of YS and 
MS when subjected to SGID insignificantly increased (P>0.05).  
 
Figure 5: LIP inhibition of young and mature soybean upon subjecting to gastric and 
gastrointestinal digestions (SGID). Values are represented in IC50 (µg/ml). Different 
small letters on each bar indicates significant difference between different samples 
analysed. Keynotes: YS-young soybean, MS-mature soybean. 
 
3.2.3.2 Cholesterol esterase (CE) inhibitory activity 
The inhibition of the CE enzyme by YS and MS extracts is depicted in Figure 
6. YS and MS samples subjected to simulated gastric and SGID have shown enhanced 
CE inhibitory activity when compared to control samples (P>0.05). Overall, YS after 
simulated gastric digestion showed the strongest inhibitory activity of CE enzyme 
while YS control showed the lowest inhibition (P<0.05). YS samples subject to 
simulated gastric digestion showed a CE inhibition with IC50 value of 29.82 ± 0.71 
µg/ml, followed by the samples subjected to SGID in which the CE inhibition 
decreased with an IC50 value of 43.32 ± 1.75 µg/ml, and then the control YS showed 
the lowest CE inhibition with IC50 value of 70.26 ± 2.81 µg/ml. On the other hand, the 
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µg/ml) than the SGID of MS samples where the inhibition decreased with IC50 values 
of (35.08 ± 0.76 µg/ml) and gastric digested samples with IC50 value of (39.53 ± 0.73 
µg/ml) (P<0.05). Generally, the control of MS was more potent to CE enzyme 
compared to YS, and the gastric digested sample of YS displayed a higher CE 
inhibition than that of MS. While the SGID sample of MS significantly higher in 
inhibiting the CE enzyme than that of YS.  
 
 
Figure 6: CE inhibition of young and mature soybean upon subjecting to gastric and 
gastrointestinal digestions (SGID). Values are represented in IC50 (µg/ml). Different 
small letters on each bar indicates significant difference between different samples 
analysed. Keynotes: YS-young soybean, MS-mature soybean. 
 
3.2.4 Antioxidant activities by young and mature soybean subject to SGID 
3.2.4.1 Ferric-reducing antioxidant power (FRAP) 
FRAP of simulated gastric digested and SGID samples from YS and MS are 
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to ferrous iron and the activity ranged from 151.5 ± 12.19 to 585.981 ± 92.71 TEAC 
µg/ml. The ferric reducing ability of YS and MS samples were improved after the 
gastric digestion and complete SGID. In the YS samples, FRAP activity insignificantly 
increased from an initial value of 151.5 ± 12.19 in the control YS to 160.12 ± 40.18 
and 203.54 ± 28.08 TEAC µg/ml (P>0.05) in simulated gastric and SGID samples, 
respectively. MS samples showed a significant increase in FRAP activity from an 
initial value of 166.94 ± 11.94 in the control MS samples to 453.72 ± 72.06 and 585.98 
± 92.71 TEAC µg/ml for simulated gastric and SGID samples, respectively (P<0.05). 
The highest FRAP activity was obtained in MS after SGID (585.981 ± 92.71 TEAC 
µg/ml), and the least activity was recorded by YS control sample (151.5 ± 12.19 TEAC 
µg/ml). The FRAP values of control sample of YS were lower than that of MS (151.5 
± 12.19 and 166.944 ± 11.94 TEAC µg/ml, respectively) (P>0.05). The reducing 
power of the gastric digested samples from MS increased significantly by 1.5-folds 
(453.722 ± 72.06 TEAC µg/ml) compared to undigested control, and for YS the FRAP 
activity increased insignificantly (151.5 ± 12.19 to 160.129 ± 40.18 TEAC µg/ml. 
Overall, MS samples showed higher reducing power compared to YS.  
3.2.4.2 2,2 -azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) radical 
scavenging activity  
ABTS radical scavenging activity of YS and MS subjected to simulated gastric 
and SGID is displayed in Table 5 and expressed in TEAC µg/ml. Both YS and MS 
displayed effectiveness in scavenging ABTS radicals. The ABTS radical scavenging 
activity increased upon simulated gastric and SGID of both YS and MS samples. 
However, the increase in radical scavenging activity in case of YS was insignificant 
(P>0.05), while there was a significant increase in case of MS samples (P<0.05). The 
highest ABTS radical scavenging activity was shown by the MS after SGID (2614.63 
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± 50.03 TEAC µg/ml) while the lowest activity was shown by MS control (2086.89 ± 
50.59 TEAC µg/ml). The control sample of YS showed a higher ABTS radical 
scavenging activity compared to the MS (2600.15 ± 60.62 vs 2086.89 ± 50.59 TEAC 
µg/m, respectively). Moreover, gastric digested samples of YS (2638.1 ± 38.93 µg/ml) 
showed higher ABTS radical scavenging activity compared to MS (2256.05 ± 47.77 
TEAC µg/ml). However, subjecting YS to complete SGID resulted in the decrease of 
ABTS radical scavenging activity from 2600.15 ± 60.62 to 2587.73 ± 27.43 TEAC 
µg/ml (P>0.05). After complete SGID, relatively similar ABTS radical scavenging 
activity was obtained for YS (2587.73 ± 27.43 µg/ml) and MS (2614.63 ± 50.03 µg/ml) 
(P>0.05). The overall results suggest that YS has proved to be a better scavenger of 
ABTS radicals compared to the MS, although the MS showed an improved ABTS 
radical scavenging activity after simulated gastric and SGID.  
3.2.5 Anti-inflammatory (AI) inhibitory activities 
The AI activity of YS and MS subjected to simulated gastric and SGID 
expressed in diclofenac sodium equivalent capacity (DSEC µg/ml) is shown in Table 
5. As can be seen from the table, all the YS and MS samples displayed varied AI 
activity ranging from 163.12 ± 20.5 to 4879.75 ± 226.0 DSEC µg/ml. A significant 
(P<0.05) increase in the AI activity was recorded after the YS and MS samples were 
subjected to simulated gastric and SGID. The SGID MS showed the highest AI activity 
(4879.75 ± 226 DSEC µg/ml) while the control of YS showed the lowest activity 
(163.12 ± 20.5 DSEC µg/ml). For YS, the AI activity of the control sample (151.5 ± 
12.19 DSEC µg/ml) have increased significantly after the gastric digestion (519.25 ± 
75.8 DSEC µg/ml), and further increase was obtained upon SGID (2427.5 ± 70.6 
DSEC µg/ml). A similar trend was also observed for MS, where the control sample 
48 
 
showed the lowest AI activity (712.75 ± 49.8 DSEC µg/ml), and then sharply increased 
after digesting the sample through the gastric and SGID (2486.87 ± 175.2 and 4879.75 
± 226. DSEC µg/ml, respectively). In general, the values of the AI activity were higher 
for MS compared to the YS (P<0.05). 
 
Table 5: Ferric-reducing antioxidant power (FRAP), 2,2 -azino-bis (3-
ethylbenzothiazoline-6-sulfonic acid) (ABTS) radical scavenging activity and anti-
inflammatory (AI) activity of young and mature soybeans after the gastric and 
simulated gastrointestinal digestion (SGID). 
 
 Treatment ABTS FRAP AI 
Young 
soybean 
Control 2600.15±60.62 c 151.50±12.19 a 163.12±20.53 a 
Gastric 
digestion 
2638.10±38.93 c 160.12±40.18 a 519.25 ±75.8 b 
SGID 2587.73±27.43 c 203.54±28.08 a 2427.50±70.63 c 
Mature 
soybean 
Control 2086.89±50.59 a 166.94±11.94 a 712.75±49.86 b 
Gastric 
digestion 
2256.05±47.77 b 453.72±72.06 b 2486.87±175.26 c 
 SGID 2614.63±50.03 c 585.98±92.71 b 4879.75±226.02 d 
Data represents mean ± SD. Different small alphabets in the same column represents 
significant difference between the samples. 
ABTS is represented in Trolox Equivalent Antioxidant Capacity (TEAC) µg/ml. 
FRAP is represented in Trolox Equivalent Antioxidant Capacity (TEAC) µg/ml. 
AI is represented in Diclofenac Sodium Equivalent Capacity (DSEC µg/ml) µg/ml. 
 
3.3 Phase 2: Effect of the enzymatic hydrolysis on bioactive properties of young 
and mature soybean protein hydrolysates 
In the phase 2, as previously mentioned young and mature soybean proteins 
were isolated and then hydrolysed using three different enzymes. The generated 
hydrolysates were analysed for different bioactive properties as described below. 
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3.3.1 Characterization of young and mature soybean protein hydrolysates upon 
enzymatic hydrolysis 
Young and mature soybean protein hydrolysate were characterized for the 
extent of hydrolysis using degree of hydrolysis (DH) assay. DH for each hydrolysate 
were expressed in %. 
3.3.1.1 Degree of hydrolysis 
The degree of hydrolysis (DH) of YS and MS protein hydrolysates generated 
by each enzyme was analyzed and expressed in terms of percentage (%) of hydrolysis 
as displayed in Figure 7. Overall, the DH of YS and MS protein hydrolysates produced 
by each enzyme showed a similar pattern in which the DH increases with increasing 
the time of hydrolysis (P<0.05). DH of YS hydrolysates produced by each enzyme 
(alcalase, bromelain, and flavourzyme) at 2, 4 and 6 h, were in a range of 31.67 ± 4.57 
to 72.39 ± 2.06 %, respectively. Alcalase derived hydrolysate at 2 h showed the lowest 
DH (31.67 ± 4.57 %) and bromelain derived hydrolysate at 6 h showed the highest DH 
(72.39 ± 2.06%). In contrast, MS protein hydrolysates showed overall higher DH 
compared to YS protein hydrolysates with values ranging from 55.22 ± 3.01 to 80.83 
± 2.2% (P<0.05). Among the MS, the highest DH (80.83 ± 2.2%) was displayed by 
alcalase derived hydrolysate at 6 h hydrolysis and the lowest DH obtained was shown 
by flavourzyme derived hydrolysate (55.22 ± 3.01%) at 2 h of hydrolysis. Among all 
the hydrolysates of YS, DH of bromelain generated hydrolysates were significantly 
higher (P<0.05) than alcalase and flavourzyme generated hydrolysates when generated 
at 4 and 6 h of hydrolysis. Similarly, among MS hydrolysates, bromelain generated 
hydrolysates showed a significantly higher DH compared to the alcalase and 
flavourzyme generated hydrolysates when generated at 2 and 4 h of hydrolysis. 
Bromelain derived YS and MS protein hydrolysates showed higher DH than alcalase 
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and flavourzyme derived hydrolysates. It is evident from this study that bromelain is 
the most effective enzyme for generating both YS and MS protein hydrolysates, having 
shown higher DH than alcalase and flavourzyme derived hydrolysates. Overall, YS 
hydrolysates were found to be less responsive to hydrolysis in comparison to MS 
hydrolysates as indicated by lower percentage of DH throughout the varying time of 
enzmaytic hydrolysis, except for flavourzyme-generated hydrolysates that showed a 
higher percentage of DH. It is noteworthy that MS hydrolysates were more responsive 
to enzymatic hydrolysis compared to YS derived hydrolysates. 
  
Figure 7: Degree of hydrolysis (DH %) of young and mature soybean protein 
hydrolysates produced by alcalase, bromelain, and flavourzyme at 2, 4 and 6 h of 
hydrolysis time. Different small letters on each bar indicates significant difference 
between different samples analysed. 
 
3.3.2 Inhibition of key enzymes related to diabetes by young and mature soybean 
protein hydrolysates  
3.3.2.1 D-amylase (AA) inhibitory activity 
AA inhibitory properties of young and mature soybean protein hydrolysates 
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shown in Figure 8 and represented as AA-inhibitory-IC50 (µg/ml). The intact protein 
of young soybean showed higher AA-inhibitory properties with an IC50 of 79.37 ± 
1.45 µg/ml compared to the intact protein of mature soybean with AA-inhibitory IC50 
value of 87.68 ± 1.41 µg/ml. All hydrolysates prepared from alcalase, bromelain, and 
flavourzyme after the hydrolysis for 2, 4, and 6 h resulted in a significant reduction in 
their AA-inhibitory IC50 values as compared to their intact proteins (P<0.05) indicating 
that hydrolysis improved the AA inhibitory properties. The AA-inhibitory properties 
demonstrated by alcalase-generated YS hydrolysates were slightly lower (P>0.05) 
than those shown by MS hydrolysates at 2 h hydrolysis time (IC50: 42.66 ± 0.86 and 
42.05 ± 0.33 µg/ml), respectively. However, at 4 h there was no significant difference 
(P>0.05) in the IC50 values between the two samples. At 6 h of hydrolysis, the IC50 
values of both YS and MS hydrolysates increased, indicating lower AA inhibition. 
Alcalase derived hydrolysates of MS showed enhanced AA inhibition compared to the 
YS hydrolysates. Bromelain-derived protein hydrolysates of YS displayed a 
significant reduction of AA inhibition after 2, 4 and 6 h of hydrolysis. AA-inhibitory 
IC50 value of 35.05 ± 0.5 µg/ml was obtained for bromelain generated YS hydrolysates 
at 2 h followed by the hydrolysates generated at 4 h and 6 h, with IC50 values of 41.3 
± 0.36 µg/ml and 48.12 ± 0.29 µg/ml, respectively. On the other hand, bromelain-
generated MS hydrolysates at 2 and 6 h of hydrolysis exhibited insignificant increase 
in the AA inhibition (P>0.05) as indicated by their lower (IC50: 41.26 ± 0.72 and 40.73 
± 0.49 µg/ml) compared to the IC50 of the hydrolysates generated at 4 h (IC50: 44.54 ± 
0.5 µg/ml) (P<0.05). The bromelain-generated hydrolysates of YS produced at 2 h 
showed a higher inhibition of AA than MS hydrolysates. However, the AA inhibition 
then decreased continuously for YS hydrolysates to 6 h compared to those of MS 
(P<0.05). Flavourzyme-digested hydrolysates of YS displayed a significantly higher 
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AA inhibition at 2 h hydrolysis with IC50 value of 26.57 ± 0.29 µg/ml followed by a 
decreased in AA inhibitory activity with the prolonged hydrolysis from 4 and 6 h 
(P<0.05). While the flavourzyme produced hydrolysates of MS showed higher 
inhibition at 4 h (IC50: 36.79 µg/ml), followed by 2 h and 6 h (IC50: 40.12 µg/ml) and 
(IC50:42.15 µg/ml), respectively. The flavourzyme-generated hydrolysates of YS 
showed a significantly lower IC50 value than MS at 2 h and 4 h of hydrolysis. However, 
an insignificant decrease was found in AA inhibitory activity of both YS and MS 
hydrolysates at 6 h of hydrolysis. 
 
 
3.3.2.2 Dipeptidyl peptidase IV (DPP-IV) inhibitory activity 
DPP-IV inhibitory activity of YS and MS hydrolysates produced by alcalase, 
bromelain, and flavourzyme at 2, 4, and 6 h of hydrolysis is shown in Figure 9. All the 
protein hydrolysates displayed higher DPP-IV inhibitory activities compared to their 
 
Figure 8: AA inhibitory activity of young and mature soybean protein hydrolysates 
produced by alcalase, bromelain, and flavourzyme at 2, 4 and 6 h of hydrolysis time. 
Values are represented in IC50 (µg/ml). Different small letters on each bar indicates 
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intact proteins. The IC50 value of the intact protein of YS (IC50: 137.5 ± 3.71 µg/ml) 
was significantly higher than MS protein (IC50: 80.788 ± 4.4 µg/ml) indicating lower 
DPP-IV inhibitory activity (P<0.05). Upon hydrolysis, 2 to 3 times increase in 
inhibition of DPP-IV was observed for both YS and MS protein hydrolysates. In 
general, MS hydrolysates produced using alcalase, bromelain, and flavourzyme at 
hydrolysis times 2, 4, and 6 h presented a similar trend in which their DPP-IV 
inhibition increased with increase in the hydrolysis time from 2 to 6 h (P<0.05), except 
for flavourzyme-generated hydrolysates at 6 h which decreased slightly in DPP-IV 
inhibition (P>0.05). For alcalase-generated hydrolysates, DPP-IV inhibition of both 
MS and YS significantly (P<0.05) increased with increased hydrolysis time. The 
highest DPP-IV inhibitory activity was recorded at 6 h hydrolysis as indicated by lower 
IC50 value for YS (39.44 ± 0.28 µg/ml) and MS (50.2 ± 0.77 µg/ml). For bromelain 
and flavourzyme produced MS protein hydrolysates, the highest DPP-IV inhibitory 
activity was recorded at 4 and 6 h of hydrolysis compared to the hydrolysates produced 
at 2 h. Overall, amongst the hydrolysates from MS protein hydrolysates, the highest 
DPP-IV inhibitory activity was displayed by flavourzyme-generated hydrolysate at 4 
h (IC50: 32.63 ± 0.18 µg/ml) compared to alcalase and bromelain generated 
hydrolysates (P<0.05). Similarly, amongst all YS protein hydrolysates, flavourzyme-
generated hydrolysates at 2 h demonstrated the highest DPP-IV inhibition with an IC50 
value of 29.26 ± 0.57 µg/ml (P<0.05). Bromelain-produced YS hydrolysates 
demonstrated an insignificant change in the DPP-IV inhibition when hydrolysis time 
increased from 2 to 6 h (P>0.05). The DPP-IV inhibitory activity of alcalase-derived 
hydrolysates of YS significantly increased when the hydrolysis was prolonged up to 6 
h (P<0.05). The alcalase-generated hydrolysates of YS displayed lower IC50 values in 
comparison to MS generated hydrolysates (P<0.05) at different times of hydrolysis. 
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Similarly, for bromelain-generated hydrolysates, the IC50 value of YS hydrolysates 
was significantly lower (P<0.05) than MS hydrolysates. However, at 6 h of hydrolysis, 
an insignificant change in the IC50 value was observed between MS and YS 
hydrolysates (P>0.05). The IC50 value of flavourzyme-generated hydrolysates of YS 
at 2 h was significantly lower than that of MS derived hydrolysates. Flavourzyme-
generated hydrolysates of YS showed an opposite trend to those of MS, where the IC50 
values of MS hydrolysates decreased compared to YS hydrolysates when the time of 
hydrolysis increased from 2 to 6 h. Overall, the results obtained revealed that 
flavourzyme generated YS hydrolysates at 2 h and MS hydrolysates at 4 h hydrolysis 





Figure 9: DPP-IV inhibitory activity of young and mature soybean protein 
hydrolysates produced by alcalase, bromelain, and flavourzyme at 2, 4 and 6 h of 
hydrolysis time. Values are represented in IC50 (µg/ml). Different small letters on 
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3.3.3 Inhibition of key enzymes related to obesity by young and mature soybean 
protein hydrolysates  
3.3.3.1 Pancreatic lipase (LIP) inhibitory activity  
Pancreatic LIP inhibitory displayed by YS and MS protein hydrolysates is 
displayed in Figure 10. As indicated LIP inhibitory activity was significantly enhanced 
after the hydrolysis by different enzymes when compared to their intact soybean 
proteins (P<0.05). The unhydrolyzed protein of YS (IC50: 100.55 ± 1.44 µg/ml) was 
more effective in inhibiting the LIP activity in comparison to the unhydrolyzed MS 
protein (IC50: 137.9 ± 9.1 µg/ml) (P<0.05). Alcalase-produced YS hydrolysate showed 
higher LIP inhibitory properties compared to MS protein hydrolysates counterpart 
(P<0.05). Alcalase 4 and 6 h generated YS hydrolysates exhibited the highest LIP 
inhibition with an IC50 value of 38.21 ± 1.8 and 35.75 ± 0.38 µg/ml, respectively 
(P>0.05) compared to the IC50 values of the hydrolysates produced at 2 h (43.33 ± 2.17 
µg/ml) (P<0.05). Bromelain-produced YS protein hydrolysate showed highest 
inhibition of LIP at 2 h with IC50 value of 30.04 ± 0.15 µg/ml, which decreased when 
the hydrolysis was extended to 4 and 6 h (IC50: 38.76 ± 0.25 and 37.96 ± 0.88 µg/ml), 
respectively (P<0.05). Flavourzyme-digested YS protein hydrolysate at 2 h displayed 
insignificantly higher LIP inhibition with IC50 value of 30.41 ± 0.18 µg/ml compared 
to YS hydrolysates generate at 4 and 6 h of hydrolysis (IC50: 33.04 ± 0.18 and 36.94 ± 
0.23 µg/ml), respectively (P>0.05). In contrast, MS hydrolysate produced by 
flavourzyme showed a higher inhibition at 4 h with IC50 value of 65.15 ± 3.52 µg/ml, 
followed by 2 h (IC50: 80.15 ± 3.78 µg/ml), and 6 h (IC50: 85.52 ± 7.57 µg/ml) 
generated hydrolysates (P<0.05). Similar trend was observed for the MS hydrolysates 
produced by bromelain which shows highest LIP inhibition at 4 h of hydrolysis with 
IC50 value of 92.71 ± 6.14 µg/ml, followed by 2 h (IC50: 99.51 ± 8.23 µg/ml) and 4 h 
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(IC50: 111.8 ± 5.18 µg/ml) generated hydrolysates, respectively. Alcalase-produced 
hydrolysates of MS displayed non-significant difference in LIP inhibition at different 
times of hydrolysis (P>0.05), except that the inhibition was slightly enhanced at 4 h of 
hydrolysis. Overall, the LIP inhibitory activity demonstrated by YS hydrolysates 
produced by alcalase, bromelain, and flavourzyme throughout the different hydrolysis 
time periods were significantly higher compare to the MS derived hydrolysates 
(P<0.05). 
 
3.3.3.2 Cholesterol esterase (CE) inhibitory activity 
The inhibition of CE by YS and MS protein hydrolysates generated by alcalase, 
bromelain, and flavourzyme at 2, 4, and 6 h of hydrolysis is shown in Figure 11. YS 
and MS hydrolysates exhibited a higher CE inhibition than their intact proteins 
(P<0.05), and MS protein (IC50: 79.8 ± 2.36 µg/ml) displayed a significantly lower 
IC50 value than YS protein (IC50: 88.23 ± 2.85 µg/ml). YS protein hydrolysates 
 
Figure 10: LIP inhibitory activity of young and mature soybean protein hydrolysates 
produced by the alcalase, bromelain, and flavourzyme at 2, 4, and 6 h of hydrolysis 
time. Values are represented in IC50 (µg/ml). Different small letters on each bar 
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produced by all three enzymes showed a similar trend for CE inhibition, where the 
highest inhibition of CE was observed at 2 h hydrolysis, and then a decrease in CE 
inhibition was noticed with prolonged hydrolysis for 4 and 6 h (P<0.05). It is observed 
that among the YS protein hydrolysates produced at 2 h of hydrolysis time, 
flavourzyme-produced hydrolysates displayed a significantly higher CE inhibitory 
activity with an IC50 value of 27.08 ± 0.43 µg/ml compared to those produced by 
alcalase and bromelain (P<0.05). YS protein hydrolysate generated by alcalase and 
bromelain at 2 h displayed CE inhibitory IC50 values of 44.98 ± 1.24 µg/ml and 60.95 
± 1.99 µg/ml, respectively. In case of MS protein hydrolysate, flavourzyme generated 
hydrolysates displayed the most potent CE inhibitory activity followed by alcalase, 
and bromelain. CE inhibitory activity of alcalase-generated MS hydrolysates 
decreased when hydrolysis time increased from 2 to 4 h (P<0.05) followed by no 
significant change at 6 h of hydrolysis (P>0.05). The CE-inhibitory IC50 value of 36.25 
± 0.59 µg/ml and 34.73 ± 0.29 µg/ml were reported for alcalase-generated MS 
hydrolysates at 4 and 6 h of hydrolysis (P>0.05), respectively, which increased 
significantly to 46.7 ± 1.22 µg/ml at 2 h hydrolysis (P<0.05). While bromelain-
produced hydrolysates exhibited a highest inhibition of CE at 2 h (IC50: 47.33 ± 5.07 
µg/ml) followed by reduction in the inhibition at 4 h (IC50: 53.43 ± 4.67 µg/ml) and 6 
h (IC50: 61.37 ± 8.57 µg/ml) (P<0.05). Despite the fact that flavourzyme-produced MS 
protein hydrolysates were most efficient in inhibiting CE compared the alcalase and 
bromelain, however, no significant increase in CE inhibition with increase of 
hydrolysis time was noticed at 4 and 6 h (P>0.05). In general, alcalase-generated YS 
hydrolysates at 2 h showed no significant difference from alcalase generated MS 
hydrolysate (P>0.05). Furthermore, an opposite trend was observed in the CE 
inhibitory activity of both MS and YS alcalase generated hydrolysates as the 
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hydrolysis duration progresses. For YS hydrolysates, a continuous decrease in their 
CE inhibitory activity with prolonged hydrolysis time was recorded, while those of 
MS inhibitory activity were significantly enhanced with increase of hydrolysis time 
from 2 to 6 h. The IC50 value of bromelain-generated hydrolysates of MS was 
significantly lower than YS hydrolysates (P<0.05). However, YS hydrolysate at 2 h 
were not significantly different (P>0.05) from MS hydrolysate at 6 h. Flavourzyme-
generated hydrolysates of YS at 2 h were significantly lower in IC50 than that of MS 
at the same hydrolysis time and was the best among all hydrolysates in inhibiting CE. 
This result suggested that flavourzyme-generated YS hydrolysates at 2 h demonstrated 
the most potent CE inhibitory activity. Although the IC50 values of flavourzyme-
generated MS hydrolysates at 4 and 6 h were significantly lower compared to those of 




Figure 11: CE inhibitory activity of young and mature soybean protein hydrolysates 
generated by the alcalase, bromelain, and flavourzyme at 2, 4 and 6 h of hydrolysis 
time. Values are presented as IC50 (µg/ml). Different small letters on each bar 
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3.3.4 Antioxidant properties of young and mature soybean protein hydrolysates 
3.3.4.1 Ferric-reducing antioxidant power (FRAP) 
The ferric reducing antioxidant power (FRAP) of YS and MS protein 
hydrolysates is displayed in Table 6 and expressed as TEAC µg/ml. The FRAP varied 
significantly (P<0.05) between the hydrolyzed and unhydrolyzed samples of YS and 
MS generated by alcalase, bromelain, and flavourzyme at 2, 4, and 6 h of hydrolysis 
except for all 2 h hydrolysates from YS. YS and MS unhydrolyzed protein samples 
displayed the lowest reducing power (211.8 ± 12.65 and 587.37 ± 100.09 TEAC µg/ml, 
respectively) compared to the hydrolyzed samples. Unhydrolyzed MS protein 
exhibited a stronger FRAP activity than YS protein (P<0.05). The highest reducing 
power was shown by flavourzyme-generated MS at 6 h hydrolysis (1502.93 ± 71.79 
TEAC µg/ml) while the lowest was shown by flavourzyme-generated YS at 2 h 
(229.88 ± 24.98 TEAC µg/ml). For YS, the bromelain-generated YS hydrolysate at 6 
h showed a significantly higher reducing power with values of 823.29 ± 49.25 TEAC 
µg/ml compared to the alcalase and flavourzyme generated hydrolysates (P<0.05). YS 
hydrolysates generated from bromelain enzyme demonstrated the most effective 
reducing power, followed by alcalase, and flavourzyme. It is evident from this study 
that flavourzyme-generated YS hydrolysates displayed an increase in FRAP when 
hydrolysis progressed from 2 to 4 h (229.88 ± 24.98 to 572.12 ± 24.6), and then 
decreased at 6 h (396.32 ± 51.88 TEAC µg/ml). On the other hand, MS hydrolysates 
generated by flavourzyme showed a significant increase in the FRAP values (1113.27 
± 46.14 to 1502.93 ± 71.79 TEAC µg/ml) with the increase of hydrolysis time from 2 
to 6 h. Alcalase-generated YS and MS protein hydrolysates both displayed increase in 
FRAP with the increase in hydrolysis time from 2 to 6 h with values ranging from 
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280.59 ± 25.83 to 704.12 ± 37.7 and 993.39 ± 55.56 to 1400.83 ± 70.55 TEAC µg/ml, 
respectively. However, MS hydrolysates displayed stronger FRAP (P<0.05) than the 
YS hydrolysates. Moreover, bromelain-generated YS hydrolysates also displayed an 
increase in FRAP with the increase in hydrolysis time from 2 to 6 h (285.83 ± 30.79 
to 823.29 ± 49.25 TEAC µg/ml), however, for MS hydrolysates generated by 
bromelain, an increase in FRAP from 2 to 4 h (1190.8 ± 52.92 to 1294.47 ± 95.89 
TEAC µg/ml) was followed by a slight decrease (P>0.05) at 6 h of hydrolysis (1284.75 
± 48.36 TEAC µg/ml). In general, FRAP of alcalase, bromelain, and flavourzyme-
generated hydrolysates of MS were higher than those of YS throughout the hydrolysis 
time, and all these hydrolysates displayed stronger reducing powers as the hydrolysis 
time increased (P<0.05), except for flavourzyme-generated hydrolysates of YS. 
 
Table 6: Ferric-reducing antioxidant power (FRAP) of young and mature soybeans 
protein hydrolysates generated by alcalase, bromelain, and flavourzyme at 2, 4, 6 h 
of hydrolysis. 
 
Enzyme Time Young Soybean Mature Soybean 
Control 0 h 211.8 ± 12.65 a 587.37 ± 100.09 c 
Alcalase 
2 h 280.59 ± 25.83 a 993.39 ± 55.56 f 
4 h 427.7 ± 51.8 b 1041.32 ± 13.31 fg 
6 h 704.12 ± 37.7 d 1400.83 ± 70.55 jk 
Bromelain 
2 h 285.83 ± 30.79 a 1190.8 ± 52.92 hi 
4 h 604.53 ± 31.03 cd 1294.47 ± 95.89 ij 
6 h 823.29 ± 49.25 e 1284.75 ± 48.36 i 
Flavourzyme 
2 h 229.88 ± 24.98 a 1113.27 ± 46.14 gh 
4 h 572.12 ± 24.60 c 1252.56 ± 6.00 i 
6 h 396.32 ± 51.88 b 1502.93 ± 71.79 k 
 
Data represents mean ± SD. Different small alphabets in the table represents 
significant difference between the samples. FRAP is represented in Trolox 




3.3.4.2 2,2 -azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) radical 
scavenging activity 
ABTS radical scavenging activity of YS and MS protein hydrolysates 
generated by alcalase, bromelain, and flavourzyme for 2, 4, and 6 h is present in Table 
7 and expressed as Trolox Equivalent Antioxidant Capacity (TEAC) µg/ml. The 
unhydrolyzed samples of YS and MS showed the lowest ABTS radical scavenging 
activity (1602.02 ± 144.98 and 1810.94 ± 105.96 TEAC µg/ml), respectively, and MS 
unhydrolyzed protein displayed insignificantly higher activity than YS unhydrolyzed 
protein (P>0.05). Upon hydrolysis, all YS derived hydrolysates exhibited a 
significantly (P<0.05) higher ABTS radical scavenging activity compared to control 
YS soybean protein samples, except alcalase 2 h generated hydrolysate (P>0.05). The 
highest ABTS radical scavenging activity among YS and MS was found in alcalase 
generated hydrolysate at 6 h of hydrolysis (2538.38 ± 44.65 TEAC µg/ml and 2428.07 
± 194.78 TEAC µg/ml, respectively). Alcalase-generated hydrolysates of MS 
displayed insignificantly (P>0.05) higher ABTS radical scavenging activity than 
flavourzyme and bromelain generated hydrolysates. In addition, alcalase-generated 
hydrolysates of MS at 2 h were insignificantly higher in scavenging of ABTS radicals 
than that of YS (P>0.05). However, at 4 h of hydrolysis, an insignificant increase was 
observed (P>0.05) for both MS and YS hydrolysates, and at 6 h of hydrolysis, ABTS 
radical scavenging activity of YS hydrolysates insignificantly increased compared to 
MS hydrolysates (P>0.05). For bromelain-generated hydrolysates at 2 h of hydrolysis, 
ABTS radical scavenging activity of YS hydrolysates (2077.47 ± 63.7TEAC µg/ml) 
was slightly higher (P>0.05) than MS hydrolysates (2063.08 ± 399.14TEAC µg/ml). 
An insignificant increase in the ABTS radical scavenging activity was observed 
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(P>0.05) in both YS and MS hydrolysates at 4 and 6 h of hydrolysis. Flavourzyme 
generated hydrolysates of YS and MS showed an insignificant increase in ABTS 
radical scavenging and ranged from (2143.64 ± 79.58 to 2476.77 ± 90.34 TEAC 
µg/ml) and (1827.47 ± 137.87 to 2166.84 ± 423.64 TEAC µg/ml), respectively. 
Flavourzyme-generated hydrolysates of YS showed an insignificant ABTS radical 
scavenging activity (P>0.05) compared to MS hydrolysates when produced at 2, 4, and 
6 h of hydrolysis. The overall results suggest that YS and MS hydrolysates generated 
by different enzymes at various hydrolysis times improved ABTS radical scavenging 
activity than their intact protein samples. 
 
 
Table 7: 2,2 -azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) radical 
scavenging activity of young and mature soybeans protein hydrolysates produced 
by alcalase, bromelain, and flavourzyme at 2, 4 and 6 h of hydrolysis. 
Enzyme Time Young Soybean Mature Soybean 
Control 0 h 1602.02 ± 144.98 a 1810.94 ± 105.96 ab 
Alcalase 
2 h 1994.49 ± 84.09 abc 2147.01 ± 317.74 bcdef 
4 h 2293.47 ± 53.83 cdef 2239.78 ± 120.37 cdef 
6 h 2538.38 ± 44.65 f 2428.07 ± 194.78 def 
Bromelain 
2 h 2077.47 ± 63.7 bcde 2063.08 ± 399.14 bcd 
4 h 2122.03 ± 17.15 bcde 2120.84 ± 141.49 bcde 
6 h 2287.89 ± 81.84 cdef 2253.15 ± 251.73 cdef 
Flavourzyme 
2 h 2143.64 ± 79.58 bcdef 1827.47 ± 137.87 ab 
4 h 2203.01 ± 61.14 bcdef 2068.49 ± 251.19 bcd 
6 h 2476.77 ± 90.34 ef 2166.84 ± 423.64 bcdef 
 
Data represents mean ± SD. Different small alphabets in the table represents 
significant difference between the samples. ABTS is represented in Trolox 
Equivalent Antioxidant Capacity (TEAC) µg/ml. 
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3.3.4.3 2,2’-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity 
The DPPH radical scavenging activity of YS and MS protein hydrolysates is 
depicted in Table 8. The data shows that all the hydrolysates generated by different 
enzymes at various hydrolysis times possess significant DPPH radical scavenging 
potential. The unhydrolyzed (control) samples of YS and MS proteins showed the 
lowest DPPH radical scavenging activity with values of 827.69 ± 40.9 and 1079.69 ± 
90.63 TEAC µg/ml, respectively. During the progression of hydrolysis, the DPPH 
radical scavenging activity of YS and MS protein hydrolysates increased with the 
increase in the hydrolysis time from 2 to 6 h. The highest DPPH radical scavenging 
activity was displayed by the MS protein hydrolysate generated with bromelain at 6 h 
(3658.02 ± 86.5 TEAC µg/ml), followed by the YS hydrolysates generated with 
alcalase at 6 h with value of 2471.79 ± 82.57 TEAC µg/ml. Among YS hydrolysates, 
DPPH radical scavenging activity of the alcalase generated hydrolysates displayed a 
significant increase (P<0.05) with the increase in time of hydrolysis from 2 h to 6 h 
(1105.25 ± 89.36 to 2471.79 ± 82.57 TEAC µg/ml). While the YS hydrolysates 
generated by bromelain and flavourzyme showed an insignificant (P>0.05) increase of 
DPPH radical scavenging activity from 2 h to 4 h of hydrolysis and followed by a 
significant increase at 6 h of hydrolysis with values of 2450.51 ± 42.81 and 2247.94 ± 
33.65 TEAC µg/ml, respectively. Bromelain generated hydrolysates of MS showed a 
remarkable increase in DPPH radical scavenging activity from 2188.46 ± 152.45 to 
3658.02 ± 86.5 TEAC µg/ml when the hydrolysis time increased from 2 to 6 h 
compared to those of YS (1763.44 ± 53.96 to 2450.51 ± 42.81 TEAC µg/ml) (P<0.05). 
Overall, the results showed that DPPH radical scavenging activity exhibited by MS 
hydrolysates was significantly higher than those exhibited by YS hydrolysates. 
Interestingly, bromelain was most effective in generating YS and MS hydrolysates 
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with potential DPPH radical scavenging activities. The flavourzyme generated 
hydrolysates of YS displayed an insignificant increase in DPPH radical scavenging 
activity when time of hydrolysis increased from 2 to 4 h of hydrolysis (P>0.05), which 
was followed by a significant increase when time of hydrolysis increase to 6 h in case 
of both YS and MS (P<0.05). 
3.3.5 Anti-inflammatory (AI) properties of young and mature soybean protein 
hydrolysates 
The ability of YS and MS protein hydrolysates to inhibit the inflammation in 
the in-vitro conditions is displayed in Table 9 and presented as diclofenac sodium 
Table 8: 2,2 -diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity of 
young and mature soybeans protein hydrolysates produced by alcalase, bromelain, 
and flavourzyme at 2, 4 and 6 hours of hydrolysis. 
Enzyme Time Young Soybean Mature Soybean 
Control 0 h 827.69 ± 40.9 a 1079.69 ± 90.63 b 
Alcalase 
2 h 1105.25 ± 89.36 b 1596.71 ± 91.48 c 
4 h 1744.83 ± 92.95 cde 1705.64 ± 94.22 cde 
6 h 2471.79 ± 82.57 h 2034.35 ± 96.82 f 
Bromelain 
2 h 1763.44 ± 53.96 cde 2188.46 ± 152.45 fg 
4 h 1864.02 ± 36.07 e 2316.69 ± 37.33 gh 
6 h 2450.51 ± 42.81 h 3658.02 ± 86.5 i 
Flavourzyme 
2 h 1774.48 ± 72.67 de 1638.15 ± 75.83 cd 
4 h 1838.97 ± 78.66 e 1861.78 ± 68.19 e 
6 h 2247.94 ± 33.65 g 2465.25 ± 77.18 h 
 
Data represents mean ± SD. Different small alphabets in the table represents 
significant difference between the samples. DPPH is represented in Trolox 




equivalent capacity (DSEC µg/ml). All the generated YS and MS hydrolysates showed 
an AI activity that varied when different enzymes were used for various times of 
hydrolysis. Unhydrolyzed YS and MS protein isolate samples displayed the lowest AI 
activities with values of 3355.71 ± 42.93 and 3595.08 ±74.85 DSEC µg/ml, 
respectively, and both unhydrolyzed samples displayed insignificant difference 
amongst each other (P>0.05). Upon hydrolysis, AI activity increased in all the 
hydrolysates with the highest activity reported in bromelain-generated YS 
hydrolysates at 4 h (7527.83 ± 164.18 DSEC µg/ml) while the lowest activity was 
shown by the flavourzyme generated YS hydrolysate at 2 h (3777.58 ± 214.68 DSEC 
µg/ml) (P<0.05). For MS, alcalase-generated hydrolysates at 4 h showed the highest 
AI activity (5912.08 ± 30.92 DSEC µg/ml), followed by bromelain 4 h (5674.66 ± 
71.45 DSEC µg/ml) and alcalase 6 h (5347.5 ± 27.55 DSEC µg/ml) generated 
hydrolysates which did not different significantly from each other (P>0.05). Alcalase 
and bromelain generated MS hydrolysates showed a similar trend where significantly 
higher (P<0.05) AI activity was displayed by the hydrolysates produced at 4 h 
hydrolysis time (5912.08 ± 30.92 and 5674.66 ± 71.45 DSEC µg/ml), respectively 
followed by a decline in the activity at 6 h. While for flavourzyme-generated MS 
hydrolysates, those produced at 2 h hydrolysis time showed a higher AI activity 
(4787.16 ± 72.29 DSEC µg/ml) than the hydrolysates produced at 4 h (4573.74 ± 37.25 
DSEC µg/ml), and then the activity increased significantly at 6 h (4857.24 ± 59.33 
DSEC µg/ml) compared to 4 h but was not significantly different to the hydrolysates 
generated at 2 h of hydrolysis (P>0.05). While for YS, hydrolysates produced by 
alcalase and bromelain showed higher AI activity than flavourzyme generated 
hydrolysates (P<0.05). Alcalase-generated hydrolysates of YS showed a significant 
increase in the AI activity when the time of hydrolysis increased from 2 h (5639.58 ± 
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314.95 DSEC µg/ml) to 4 h (5907.33 ± 138.63 DSEC µg/ml) (P>0.05) and further to 
6 h (7185.08 ± 13.68 DSEC µg/ml) (P<0.05). Bromelain-generated hydrolysates of 
YS and MS displayed a similar trend where the hydrolysates produced at 4 h showed 
a maximum AI activity (7527.83 ± 164.18 and 5674.66 ± 71.45 DSEC µg/ml, 
respectively) which further declined at 6 h of hydrolysis time (6868.16 ± 208.82 and 
4191.66 ± 173.38 µg/ml, respectively). On the other hand, the AI activity of the 
flavourzyme-generated YS hydrolysates showed an increase with the increase in time 
of hydrolysis from 2 to 6 h (3777.58 ± 214.68 to 5050.5 ± 134.08 DSEC µg/ml, 
respectively) (P<0.05). When comparing between alcalase generated YS and MS 
hydrolysates, alcalase-generated hydrolysates of YS at 2 h were effective against 
inflammation in comparison to those of MS (P<0.05). MS and YS hydrolysates 
exhibited an insignificant increase against inflammation at 4 h of hydrolysis (P>0.05). 
However, YS hydrolysates produced at 6 h of hydrolysis showed a significant AI 
activity than MS hydrolysates. For bromelain-generated hydrolysates, the AI activity 
of YS was significantly higher (P<0.05) than those of MS. At 4 h of hydrolysis, both 
YS and MS hydrolysates displayed higher activity against inflammation than those 
produced at 2 h of hydrolysis, however, the hydrolysates of YS were more potent 
compared to those of MS (P<0.05). Further hydrolysis up to 6 h showed a significant 
reduction in the AI activity for both MS and YS hydrolysates, although, hydrolysates 
of YS were more effective than MS (P<0.05). On the other hand, flavourzyme-
generated hydrolysates of MS were significantly higher against inflammation than YS 
at 2 h of hydrolysis, although no significant difference (P>0.05) was observed in both 
MS and YS produced at 4 h. Furthermore, the AI activity of YS hydrolysates increased 
significantly compared to MS hydrolysates at 6 h hydrolysis. Overall, the results 
indicated that alcalase generated MS hydrolysates showed higher AI activities, while 
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bromelain-generated YS hydrolysates produced at 4 h were more effective against 
inflammation than alcalase and flavourzyme generated hydrolysates. 
 
Table 9: Anti-inflammatory activity of young and mature soybeans protein 
hydrolysates produced by alcalase, bromelain, and flavourzyme at 2, 4 and 6 hours 
of hydrolysis. 
Enzyme Time Young soybean Mature soybean 
Control 0 h 3355.71 ± 42.93 a 3595.08 ± 74.85 a 
Alcalase 
2 h 5639.58 ± 314.95 f 5036 ± 54.69 e 
4 h 5907.33 ± 138.63 f 5912.08 ± 30.92 f 
6 h 7185.08 ± 13.68 g 5347.5 ± 27.55 f 
Bromelain 
2 h 4638.16 ± 69.23 d 4553.25 ± 166.88 c 
4 h 7527.83 ± 164.18 h 5674.66 ± 71.45 f 
6 h 6868.16 ± 208.82 g 4191.66 ± 173.38 b 
Flavourzyme 
2 h 3777.58 ± 214.68 b 4787.16 ± 72.29 d 
4 h 4235.33 ± 241.79 c 4573.74 ± 37.25 c 
6 h 5050.5 ± 134.08 e 4857.24 ± 59.33 d 
 
Data represents mean ± SD. Different small alphabets in the same column 
represents significant difference between the samples. Anti-inflammatory is 
represented in Diclofenac Sodium Equivalent Capacity (DSEC µg/ml) µg/ml. 
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Chapter 4: Discussion 
 
4.1 Proximate composition 
Proximate analysis determines the major components of food including 
moisture, fat, ash (total minerals), protein, and carbohydrate contents (Nielsen, 2010). 
The moisture content of dried YS seeds was higher than MS seeds and is in agreement 
with previous studies (Redondo-Cuenca et al., 2007). Overall, the values for ash 
content of MS (5.28%) corresponds well with those reported by Li et al. (2012) and 
Redondo-Cuenca et al. (2007), while ash content of YS (4.67%) was slightly lower 
than 4.89% as reported by Ren et al. (2012). The protein content of MS was found to 
be higher than YS and is in corroboration with the results obtained by (Redondo-
Cuenca et al., 2007) and (Ren et al., 2012). Although the fat content of YS (14.96%) 
agrees with previous literature (Ren et al., 2012), the values for MS were similar to 
those reported by Li et al. (2012) and slightly lesser than 18.56% reported by Redondo-
Cuenca et al. (2007). Results obtained for carbohydrate contents of YS and MS are 
also in agreement with previous research where YS was found to possess higher 
carbohydrates content than MS and is related to the fact that YS contains significantly 
higher proportions of starches (13% and 50%) in cotyledons at the beginning of 
maturation and then falls to approximately 1% in MS (Güzeler & Yildirim, 2016; 
Redondo-Cuenca et al., 2007). 
4.2 Phase 1: Effect of simulated gastrointestinal digestion (SGID) on total 
phenolic content and bioactive properties of young and mature soybeans 
4.2.1 Total phenolic content (TPC) 
Phenolic compounds are group of small molecules having a structure that 
consist of at least one phenol unit and can be classified based on their chemical 
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structure including, phenolic acids, tannins, quinones, flavonoids, coumarins, and 
curcuminoids (Gan et al., 2019). Phenolic compounds are widely distributed among 
the plant kingdom and mostly found in plant tissues such as seeds, leaves, fruits, and 
roots (de la Rosa et al., 2019).  
Various studies have reported the TPC of soybean seeds (Malen i  et al., 2007; 
Tan et al., 2017), germinated soybean (Guzmán-Ortiz et al., 2017), soymilk 
(Rodríguez-Roque et al., 2013), fermented soybeans (Ketnawa & Ogawa, 2019), and 
soybean by-products (Tyug et al., 2010). Rodríguez-Roque et al. (2013) have reported 
the changes in TPC of soymilk following in-vitro gastrointestinal digestion. It was 
observed that TPC increased significantly upon gastric and intestinal digestions 
compared to the non-digested soymilk (70.3 ± 1.8 and 69.8 ± 1.7, and 61.4 ± 1.2 mg 
GAE/ 100 ml, respectively). The author indicated that the gastric digestion influences 
the release of phenolic compounds from the soymilk matrix (Rodríguez-Roque et al., 
2013). These findings are in agreement with the results of the present study that gastric 
and intestinal digestions prompted the release of phenolic compounds from both YS 
and MS.  
The phenolic content of MS and YS, however, was found to be lesser than 
those reported by other researchers and could be attributed to differences in soybean 
variety. For instance, Liu and Xu (2015) reported the TPC content of yellow and black 
soybean as 2.75 mg GAE/g and 9.75 mg GAE/g, respectively. Whereas green soybean 
TPC was found in the range of 1.01- 1.39 mg GAE/g (Kumar et al., 2014). It is also 
reported the reproductive stage also has a profound effect on the phenolic content of 
soybean. Kumar et al. (2009) evaluated the TPC of different reproductive stages of 
soybean seed and found that maximum TPC was found at the R5 stage and then 
decreased continuously till maturity.  
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4.2.2 Inhibition of key enzymes related to diabetes by young and mature soybean 
subject to SGID 
4.2.2.1 D-amylase (AA) inhibitory activity 
The enzymes that catalyze the hydrolysis of oligosaccharides and 
polysaccharides into absorbable units are AA and D-glucosidase that contribute to 
almost 70% of carbohydrate digestion in humans (Ahmad et al., 2019). The inhibition 
of both of these enzymes is considered as a useful approach for the treatment of non-
insulin dependent diabetes (Ercan & El, 2016). The present study investigated the 
effect of SGID on the release of bioactive compounds from YS and MS with capability 
to inhibit AA. Results obtained in the present study depicted a strong enhancement in 
the -amylase inhibitory activities of both YS and MS subjected to simulated gastric 
and intestinal digestion. 
Although there are no direct comparative studies existing in the literature that 
identified the effect of simulated digestion on the AA inhibitory potential of soybeans, 
some researchers have reported the inhibitory potential of other legumes. For instance, 
Tan et al. (2017), reported the lowest AA-IC50 value of black soybean as 0.25 mg/ml, 
while 0.67 mg/ml for black turtle bean. Crude and semi purified phenolic extract 
obtained from black soybean also reported an AA-IC50 of 2.25 mg/ml and 1.60 mg/ml, 
respectively. Similarly, Ademiluyi and Oboh, (2013) investigated the ability of 
phenolic-rich extracts from soybean against AA with IC50 values as 526.32 µg/ml and 
320.51 µg/ml, respectively. These studies are in agreement with findings of the present 
study that YS and MS extracts can inhibit the AA enzyme. Apart from these, a 
multitude of studies have reported the AA inhibitory activity from different grains and 
plants such as jute leaf (Corchorus olitorius) (Oboh et al., 2012), black chokeberry 
(Aronia melanocarpa L.) (Worsztynowicz et al., 2014), and quinoa (Hemalatha et al., 
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2016; Herrera et al., 2019). For instance, Ercan and El (2016) have determined the AA 
inhibitory activity of chickpea and Tribulus terrestris upon in-vitro digestion and 
reported IC50 values of 343 µg/ml and 167 µg/ml, respectively. Similarly, phenolic 
compounds obtained from quinoa showed effective inhibition of AA with IC50 values 
of 108.68 µg/ml from quinoa bran and 148.23 µg/ml from quinoa hull, respectively 
(Hemalatha et al., 2016). Comparison of the obtained findings with the previously 
reported literature indicated that IC50 values obtained in the present study are lower 
and more potent than reported by other researchers. The results obtained further 
suggests the role of soybean towards their potential in the management of diabetes and 
its related complications. However, further studies in animal model systems are needed 
to provide strong evidence for these outcomes. 
4.2.2.2 Dipeptidyl peptidase IV (DPP-IV) inhibitory activity 
DPP-IV inhibitors are known to be as front-line treatment for the management 
of hyperglycemia in diabetic patients and in a quest to extract and identify DPP-IV 
inhibitors from natural resources. Various plant and food sources have been screened 
by many scientists globally. However, the existing literatures lack the investigations 
into the effect of SGID on the DPP-IV inhibitory action of YS and MS. Therefore, an 
attempt was made in the present study to understand the effect of simulated digestion 
process on DPP-IV inhibitory activity. The results obtained suggested an improvement 
in DPP-IV inhibitory potential of both YS and MS upon SGID treatment which might 
be attributed to the release of bioactive components like phenolics and peptides from 
soybean upon digestion.  
A previous study conducted on berry wine anthocyanins and flavonoids upon 
SGID showed DPP-IV-IC50 values of 0.07 to >300 µM and the soy isoflavone 
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genistein possess DPP-IV-IC50 of 0.48 µM which is far much lower than those obtained 
in the present study (Fan et al., 2013). The results obtained in the present study could 
be compared to the results obtained by Di Stefano et al. (2019) in which, different 
methods may influence the DPP-IV inhibitory activities. The authors investigated the 
effect of germination, heat treatment, and solid-state fermentation on the DPP-IV 
inhibitory activity of faba beans and chickpeas and indicated tremendous improvement 
in DPP-IV inhibitory activity as suggested by decline in their IC50 values. Similarly, 
anthocyanin-rich water extracts obtained from maize also showed DPP-IV activity 
with IC50 values ranging from 65.5 to 702.7 µg/ml and are comparable to those 
obtained in the present study (Zhang et al., 2019). Moreover, a Brazilian native 
Xylopia aromatica plant showed a DPP-IV-IC50 value of 0.71 mg/ml (Oliveira et al., 
2018), and a marine seaweed Turbinaria ornata showed DPP-IV-IC50 values of 55.2 
µg/ml and is equivalent to the results of the present study (Unnikrishnan et al., 2014). 
Therefore, the data suggest that YS and MS flour when subjected to SGID displayed 
potential inhibition of the DPP-IV enzyme. 
4.2.3 Inhibition of key enzymes related to obesity by young and mature soybean 
subject to SGID  
4.2.3.1 Pancreatic lipase (LIP) inhibitory activity 
LIP enzyme mainly hydrolyzes the triacylglycerols into monoacylglycerols 
and free fatty acids, so its inhibition is considered as a potential treatment for obesity 
and its related metabolic diseases (Herrera et al., 2019). Scientists worldwide have 
screened a number of resources for the existence of pancreatic LIP inhibitors. 
However, studies related to the ability of YS and MS before and after SGID against 
pancreatic LIP are still non-existent in literature. The results obtained suggested the 
presence of potent pancreatic LIP inhibitory compounds among both YS and MS. The 
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results were found to be superior in terms of lower IC50 values when compared with 
those reported by other researchers. The LIP inhibitory activity of YS and MS in the 
present study were higher compared to those obtained for phenolic extracts of lentils 
(Zhang et al., 2015), black chokeberry extracts (Worsztynowicz et al., 2014), quinoa 
and fenugreek extracts (Herrera et al., 2019). However, they were similar to those 
obtained by Tan et al. (2017), where LIP inhibitory IC50 values of the phenolic extracts 
fractions of black soybean and black turtle bean were found to be 81 µg/ml and 76 
µg/ml, respectively.  
The effect of SGID on the LIP inhibitory activities of soybean was evident and 
as explained by Liu and Xu, (2015), changes in the pancreatic LIP inhibitory potential 
was found to be related to the increased concentration of saponins among other 
phenolic compounds. In another study, the extracts of Xylopia aromatica were 
reported to inhibit pancreatic LIP with an IC50 value of 0.71 mg/ml which is 
significantly higher than the results obtained in the present study (Oliveira et al., 2018). 
Whereas, LIP inhibitory IC50 values of chickpea (9.74 µg/ml) and Tribulus terrestris 
phenolics (15.3 µg/ml) were found to be significantly lower than those obtained in 
present study (Ercan & El, 2016). The wide variation between IC50 values obtained 
from different extracts could be due to the variation in their phenolic content and other 
bioactive compounds. Hence, further investigation into the identification and 
characterization of major inhibitory fractions with potent LIP inhibition must be 
undertaken. 
4.2.3.2 Cholesterol esterase (CE) inhibitory activity 
Pancreatic cholesterol esterase (CE) is responsible for the hydrolysis of dietary 
cholesterol esters which releases the free cholesterol in the lumen of the small intestine. 
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In addition, CE promotes in combining the cholesterol into the mixed micelles and 
supports the transportation of free cholesterol to the enterocyte (Ngamukote et al., 
2011). Very few studies have investigated the cholesterol-lowering effects of plants 
and phenolics through the inhibition of CE enzyme. There are no previous literatures 
on the inhibitory activity of YS and MS upon SGID against CE enzyme. The results 
obtained from the current study are first in this direction that reports that SGID of YS 
and MS resulted in improvement of CE inhibitory activity. The improvement in CE 
inhibitory potential could be due to the release of bound phenolics upon digestion that 
might have resulted in increased inhibition of CE. A significant decline in IC50 values 
was observed upon gastric digestion which then increased upon further intestinal 
digestion and might be due to the degradation of the compounds which were released 
during simulated gastric digestion and might have not been able to interact with the 
active site of CE, thus resulting in a decrease in CE inhibition. 
Although there is no direct study related to the impact of SGID on CE 
inhibitory activities of soybean derived phenolic extract, Adisakwattana et al. (2010), 
reported a similar CE-IC50 value from the grape seed extract (27.27 µg/ml) that not 
only displayed stronger inhibition of CE under in-vitro condition but also successful 
in decreasing serum triglyceride and cholesterol levels in high fat fed rats governed 
through inhibition of lipid digestion and absorption. In addition, Ngamukote et al. 
(2011) reported a concentration dependent CE inhibition from major polyphenolic 
compounds such as gallic acid, catechin, and epicatechin from grape seeds. This study 
is the first report on the CE inhibitory potential of soybean when subjected to SGID, 
but further investigations are required in order to identify and elucidate the mechanism 
of action of potent CE inhibitory compounds originating from YS and MS upon 
gastrointestinal transit.  
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4.2.4 Antioxidant activities by young and mature soybean subject to SGID 
4.2.4.1 Ferric-reducing antioxidant power (FRAP) 
All samples of YS and MS extracts upon SGID showed significant 
improvement in ferric reducing antioxidant power (FRAP) as indicated by higher 
FRAP values in Table 5. Overall, MS was found to possess better antioxidant activity 
in terms of FRAP value than YS and could be attributed to the levels, types, and 
concentration of different phenolics at different stages of maturity. As indicated by 
Mtolo et al. (2017), the antioxidant activity of cowpeas seeds in terms of FRAP is 
significantly impacted due to the action of processing such as boiling, pressure 
cooking, and in-vitro digestion. The results obtained were similar to the present study 
where an improvement in FRAP activity was observed upon simulated digestion 
indicating the role of digestive enzymes and condition in the release of bioactive 
components capable of reducing ferric ions leading to higher FRAP values.  
Numerous studies determined the antioxidant activities of MS and YS extracts 
by measuring their reducing powers. For instance, Kumar et al. (2014) evaluated the 
reducing power of 16 immature (young) soybean genotypes, and their FRAP values 
range between (3.95 - 10.94) µM/g with a positive correlation between total isoflavone 
content and FRAP activity. The obtained results are in stark contrast to those obtained 
by Kumar et al. (2010) where they reported stronger FRAP activity among green 
soybean in comparison to black or yellow soybean due to the difference in carotenoid 
and lutein contents among yellow and black soybean. The lower FRAP values obtained 
in the present study could be attributed to variety differences between MS and YS. As 
FRAP values could be affected by the stage of maturation it could be considered as 
another reason for differences in FRAP values between YS and MS. A recent study 
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conducted into the impact of maturation stage on the reducing power of soybean 
concluded that vegetative state of soybean contains higher FRAP activity than the 
reproductive stages (Peiretti et al., 2019). The higher antioxidant activities obtained 
by ABTS assay compared to FRAP assay are attributed to the fact that ABTS assay is 
useful to the hydrophilic and lipophilic antioxidants due to the reagent, which is 
soluble in both aqueous and organic solvents, while FRAP assay is used particularly 
to water-soluble antioxidants (hydrophilic antioxidants) (Guzmán-Ortiz et al., 2017). 
4.2.4.2 2 2 -azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) radical 
scavenging activity  
The application of ABTS radicals scavenging assay has largely been employed 
to determine the scavenging abilities, in which their color reduce due to the presence 
of antioxidant-containing samples (Seo et al., 2017). In addition, ABTS radicals are 
associated with the scavenging capacities of chain breaking and hydrogen donating 
antioxidants (Lee et al., 2019). Table 5 depicts that YS and MS extracts after the 
gastrointestinal digestion has shown better antioxidant activity in terms of scavenging 
of ABTS radicals. Similar results on the effect of gastrointestinal digestion were 
reported by Apea-Bah et al. (2016) for porridges prepared with cereals and cereal
legume composites with significantly higher ABTS scavenging activity among 
digested samples of porridges when compared with the unhydrolyzed sample and was 
attributed to the release of extractable phenolics bound to proteins (Apea-Bah et al., 
2016). In addition, the obtained results also indicated a significant increase in 
scavenging activity after the complete gastrointestinal digestion compared to the 
gastric digestion. Apea-Bah et al. (2016) reported a similar observation and stated that 
in simulated duodenal digestion, the protein digestion is more effectively carried out 
by the pepsin and pancreatic protease (trypsin) rather than pepsin alone in the 
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simulated gastric digestion, which consequently led to the release more flavonoids 
bound to the proteins during the simulated duodenal digestion than in the simulated 
gastric digestion.  
Although there is a scarcity in the literature about the impact of gastric and the 
intestinal digestions of YS and MS on the antioxidant activities, a number of studies 
have reported the antioxidant activities of soybeans with possible correlation to 
existence of phenolic compounds such as isoflavones and varies from cultivar to 
cultivar and also between different substrates. For instance, Han and Baik, (2008) 
reported the ABTS radical scavenging activity of soybean (10.2 µmol TEAC g-1) and 
it was higher than those of chickpeas, yellow peas, green peas but lower than the two 
lentils (cv. Pardina and cv. Crimson). Similarly, a wide variation in ABTS radical 
scavenging was observed upon germination of soybean by Guzmán-Ortiz et al. (2017) 
which was attributed to additional synthesis of newer phenolic compounds and 
isoflavones during germination. Similar results were obtained by Lee et al. (2019), 
where solid-state fermentation of germinated soybean with Tricholoma matsutake 
remarkably increased the ABTS radicals scavenging activity. Hence, the present study 
suggests that gastrointestinal digestion could have also led to either release of bound 
phenolics or some other bioactive components (e.g. bioactive peptides and vitamins) 
that displayed more efficient scavenging of ABTS radicals.  
4.2.5 Anti-inflammatory (AI) activities 
Inflammation is a physiological process that occurs due to the bod s response 
to harmful stimuli such as infection, irritants, or damaged cells (Bouhlali et al., 2020). 
Therefore, suitable compounds capable of inhibiting the inflammatory events are much 
sought after in form of anti-inflammatory drugs. However, synthetic drugs currently 
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in use for the treatment of inflammation are widely considered unsafe due to their 
possibility to cause iatrogenic reactions, drug-related toxicity, and other adverse 
reactions that could complicate the progression of the treatment on long-term use 
(Bouhlali et al., 2020). Therefore, natural substances that can inhibit the protein 
denaturation of the tissues can be useful as safer and much convenient AI drugs (Kamal 
et al., 2018). 
In the present study, an in-vitro model of inflammation as denaturation of egg 
albumin protein was used to determine the AI activity of YS and MS extracts. The 
results were expressed as diclofenac sodium equivalent capacity and results obtained 
depicted a stronger AI activity among YS and MS extracts after the gastric and 
intestinal digestions. The results were found to be comparable to those obtained by 
Ezzat et al. (2018), where ginger extracts also showed higher AI activity (66%) by the 
inhibition of the heat induced albumin denaturation. Similarly, Moroccan date fruit 
seeds were also found to have an effective AI activity by inhibition of protein 
denaturation with IC50 values ranging from 90.34 - 193.71 g/ml which is comparable 
to the IC50 value of the diclofenac sodium (IC50 = 225.04 g/ml) (Bouhlali et al., 2020). 
The results obtained were ascribed to the protein-polyphenolic interactions and their 
positive impact on the thermal stability of proteins. It is known that the interactions of 
phenols with proteins cause changes in the secondary structure of protein leading to 
variation in their heat stability (Bouhlali et al., 2020). Hence, variations of the AI 
activity of YS and MS could be related to the phenolic composition and their 
interactions with egg albumin proteins.  
Plant extracts have shown different modes of AI activity other than their ability 
to prevent protein denaturation. Kao et al. (2007) determined the AI activity of the 
soybean cake isoflavones in animal model of inflammation and found that isoflavone 
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powders and genistein standard were effective in lowering leukocyte number and 
lipopolysaccharide (LPS)-induced inflammation (Kao et al., 2007). Similarly, Purple 
maize genotypes were also reported to have an AI activity primarily corresponding to 
the quercetin, luteolin, and rutin compounds (Zhang et al., 2019). Moreover, white 
kidney beans and round purple beans extracts have displayed high AI activity by 
decreasing the production of Nitric oxide (NO) and cytokine mRNA expression of LPS 
stimulated macrophages (García-Lafuente et al., 2014). All these studies have 
correlated the AI activities with the presence and action of phenolic compounds, which 
cannot be ruled in this study where upon SGID increase in TPC of YS and MS was 
observed. 
4.3 Phase 2: Effect of the enzymatic hydrolysis on bioactive properties of young 
and mature soybean protein hydrolysates  
The last two decades have seen increased scientific interest in the production, 
identification, and characterization of bioactive peptides from plant sources of proteins 
(Chatterjee et al., 2018; Maqsood et al., 2021). These bioactive peptides which usually 
remain hidden in their parent sequence become active upon their release in the gut due 
to the action of gut proteases and are also generated during food processing, 
fermentation, or through enzymatic hydrolysis (Singh et al., 2014). The main focus of 
the research directed towards bioactive peptides is the elucidation of their beneficial 
physiological functions and mechanism of action. Till today, immense number of soy-
derived peptides have been identified by various researchers globally with a multitude 
of biological functions including but not limited to lipid-lowering, anti-diabetic, anti-
cancerous, anti-hypertensive, AI, and antioxidant (Chatterjee et al., 2018). However, 
no such study has been extended towards the generation of bioactive peptides from YS 
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proteins, and therefore the present study was undertaken to elucidate the antidiabetic, 
anti-obesity, and antioxidant function of YS proteins in comparison to MS proteins. 
4.3.1 Characterization of protein hydrolysates obtained from young and mature 
soybean proteins 
4.3.1.1 Degree of hydrolysis (DH%) 
Small peptides and free amino acids which are generated upon enzymatic 
hydrolysis of the food proteins are known to enhance the nutritional value and 
bioactive properties of food proteins. However, sometimes higher level of hydrolysis 
leads to the development of bitter peptides that might then obstruct the application of 
these protein hydrolysates in development of new food products owing to their 
negative impact on sensorial characteristics of food products (Sun, 2011). Similarly, it 
is also important to monitor the extent of hydrolysis in order to control the hydrolysis 
process due to its probability of affecting the functional and bioactive properties of the 
hydrolysates (Jafar et al., 2018). Therefore, degree of hydrolysis (DH%), a basic 
parameter used to depict the extent of the hydrolysis and the properties of the 
hydrolysates by exhibiting the percentage of the cleaved peptide bonds must be 
analyzed (Chabanon et al., 2007). In addition, the DH% is also an indicator of the 
ability of a protease to degrade the proteinaceous substrate (Hanafi et al., 2018). 
Currently, the protein hydrolysates with high DH% (>10%), which are produced by 
the food industry are used as nutritional supplements for medicine and sport due to 
their ability to give a high solubility and optimal intestinal absorption (Marinova et al., 
2008). 
As per the results obtained in present study, the bromelain-generated YS 
protein hydrolysates showed significantly (P>0.05) higher DH values (72.39 % ± 2.06) 
at 6 h than the hydrolysates generated by alcalase and flavourzyme. These observations 
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are in agreement with those reported by Hanafi et al. (2018), where bromelain 
generated hydrolysates from green soybean showed higher DH values of around 
61.60% after 10 h of hydrolysis in comparison to alcalase, papain, and flavourzyme. 
Alcalase generated hydrolysates of both YS and MS (2 h, 4 h, 6 h) also displayed high 
DH values, and are attributed to the fact that alcalase being an endopeptidase has a 
range of specificity of peptide bonds during hydrolysis (Sbroggio et al., 2016). 
Moreover, results of the present study in Figure 7 indicates that the DH values 
increases with the hydrolysis time, which is similar to the results of Mudgil et al. 
(2018) where the DH of the camel milk protein hydrolysates increased with increasing 
hydrolysis time from 3 h to 9 h using alcalase, bromelain, and papain. Furthermore, 
the hydrolysis rate of quinoa protein hydrolysates generated by bromelain, 
chymotrypsin, and protease also showed similar increment in DH values during 
hydrolysis time progression (Mudgil et al., 2019d).  
Wang et al. (2019) have also observed that DH values of soy protein 
hydrolysates generated with alkaline protease, papain, and trypsin increased with the 
increase in hydrolysis time. However, the results obtained in present study report 
significantly higher hydrolysis of soybean proteins in comparison to those of Hrckova 
et al. (2002), where DH values upon hydrolysis of defatted soy flour using 
flavourzyme after 480 minutes showed only an increment of 3.2% to 5.1%. In general, 
these differences in DH values obtained in the present study and those obtained by 
other researchers are attributed to the differences in the reaction rate, enzyme 
specificity, and substrate affinity (Jafar et al., 2018). Moreover, alcalase is a serine 
protease, bromelain and papain are cysteine protease and flavourzyme contains a 
mixture of exo and endopeptidases with unique flavor generation and debittering 
benefits. Alcalase is reported to possess a very broad substrate specificity and hence is 
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considered as one of the most efficient enzymes in the generation of hydrolysates from 
a variety of proteins (Jung et al., 2016). Even papain and bromelain differ in their 
specificity towards proteins as papain hydrolyses peptide bonds contributed by an 
adjacent amino acid lysine, arginine and phenyl-alanine while bromelain preferred 
amino acid next to lysine, arginine, phenylalanine, and tyrosine (Wan Mohtar et al., 
2014). Therefore, variation observed in degree of hydrolysis when different enzymes 
are used for hydrolysis is because of various factors discussed above. 
4.3.2 Inhibition of key enzymes related to diabetes by young and mature soybean 
protein hydrolysates  
A number of previous studies have correlated the consumption of soybean and 
their action in the maintenance of glucose homeostasis in diabetic patients (Chatterjee 
et al., 2018). Generally, in humans glucose homeostasis is regulated through combine 
actions of two incretin hormones (Glucose-Dependent Insulinotropic Polypeptide 
(GIP) and Glucagon-Like Peptide-1 (GLP-1)) that governs the secretion of insulin 
from pancreatic -cells that in turn regulates the cellular uptake of blood glucose 
keeping their level in check (Silveira et al., 2013). However, the action of these incretin 
hormones is negatively impacted by the action of a human serine protease, dipeptidyl 
peptidase-IV (DPP-IV) causing the degradation of incretin hormones and thus reduced 
insulin secretion. Similarly, D-amylase (AA), an enzyme that is responsible for the 
hydrolysis of starch carbohydrates in the digestive system increases the levels of blood 
glucose upon food consumption causing postprandial hyperglycemia (Garza et al., 
2017). Blocking the hydrolysis of complex starches to simple sugars in the small 
intestine thus could lead to decreased rate of carbohydrate digestion and reduced 
absorption of glucose in the blood (Vilcacundo et al., 2017). Therefore, inhibition of 
AA and DPP-IV is considered as a prime therapeutic strategy for controlling the 
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menacing effects of diabetes. Owing to the side effects associated with synthetic AA 
inhibitor Acarbose (Sun et al., 2017), natural alternatives devoid of any side effects 
are needed. Numerous studies have indicated the antidiabetic roles of soy-derived 
peptides with mechanism unknown and it is therefore, anticipated that they could be 
exerting their antidiabetic action through inhibition of these enzymes (Sanjukta & Rai, 
2016). 
4.3.2.1 -amylase (AA) inhibitory activity 
Although there are some existent studies that report the AA inhibitory potential 
of mature soybean hydrolysates. Till date, there are no previous studies regarding the 
AA inhibitory potential of YS hydrolysates. Keeping this in consideration, a 
comparative investigation into the AA inhibitory activities of YS and MS protein 
hydrolysates have been investigated using in-vitro assays.  
The results of the current study suggest that YS hydrolysates are better 
inhibitors of AA in comparison to MS hydrolysates. In addition, it was also observed 
that flavourzyme and bromelain derived hydrolysates displayed better inhibition of 
AA compared to alcalase generated hydrolysates. With the change in time of 
hydrolysis, a variable effect was observed where hydrolysates generated at 2 h 
displayed higher inhibitory activity against AA than those obtained after 4 and 6 h. 
These results could be attributed to the fact that inhibition of AA enzymes is strictly 
regulated by amino acid sequences present in the peptides and therefore, it is 
anticipated that peptides generated at 2 h were more potent inhibitor to AA and could 
have been further degraded to less inhibitory peptides upon further hydrolysis (Mudgil 
et al., 2019a; Nongonierma & FitzGerald, 2019). Overall, the results obtained in the 
present study were found to be superior than those obtained by González-Montoya et 
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al. (2018a), where an IC50 value of 1.70 mg/ml was reported for germinated soybean 
protein digest upon SGID against salivary AA. Similarly, Ademiluyi et al. (2014) have 
reported AA inhibitory activity of fermented soybean condiment in diabetic rats both 
under in-vitro and in-vivo conditions in a concentration dependent manner with AA-
IC50 alue of 1063.8 g/ ml.  
Legumes in general are considered a rich source of peptides with significant 
antidiabetic activities. In one such similar study Ngoh and Gan (2016), reported the 
AA inhibitory action of pinto bean protein hydrolysates produced by protamex 
hydrolysis. However, the AA-IC50 values obtained in the present study are far higher 
than those obtained from moringa seeds protein hydrolysates with an AA inhibitory 
IC50 alue of 0.123 g/ ml (Garza et al., 2017). Overall, the obtained results shows that 
the bromelain and flavourzyme derived YS protein hydrolysates displayed excellent 
AA inhibitory properties and thus could have positive implication in management of 
diabetes. 
4.3.2.2 Dipeptidyl peptidase IV (DPP-IV) inhibitory activity 
The inhibition of DPP-IV has been considered as a novel strategy for managing 
Type 2 diabetes mellitus (Mada et al., 2019). The inhibitors of DPP-IV were one of 
the first classes of oral antidiabetic drugs to be prospectively -as anti designed 
IV inhibitory protein hydrolysates are widely being -. DPPagents hyperglycemic
dairy and  )Deacon & Lebovitz, 2016( explored in various food products such as plant
egg  ,)c2019 et al.,Mudgil (, camel skin gelatin )2014 et al., Nongonierma( proteins
et al., Salcedo -Velarde(, amaranth )2015 et al.,Zambrowicz (product -yolk protein by
 .)2018 et al.,Lammi ( soybean and lupin ,)2020 et al.,Mudgil (, quinoa )2013 Results 
obtained regarding DPP-IV inhibitory activities of YS and MS protein hydrolysates 
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revealed a significant increase in DPP-IV inhibitory activities upon hydrolysis. Intact 
proteins also showed inherent DPP-IV inhibitory activity which is in line with previous 
reports (Chatterjee et al., 2018; Sanjukta & Rai, 2016). Interestingly, among intact 
proteins, the DPP-IV-IC50 value was found to be higher for YS protein in comparison 
to MS protein. However, upon hydrolysis, it was observed that YS protein 
hydrolysates were more potent inhibitor than MS protein hydrolysates. The DPP-IV 
IC50 values obtained are comparable to the existing literature.  
For instance, González-Montoya et al. (2018a) reported that the SGID derived 
samples of germinated soybean proteins were found to inhibit DPP-IV with an IC50 
value of 1.49 ± 0.14 mg/ml. It was also reported that fractionation of germinated 
soybean digest through 5 and 10 kDa membrane displayed more effective DPP-IV 
inhibition with IC50 values 0.91 ± 0.17 and 1.18 ± 0.15 mg/ml, respectively. 
Furthermore, Wang et al. (2019) reported an inhibitory activity of DPP-IV with an 
IC50 value of 2.73 mg/ml when soy protein hydrolysates were produced by alkaline 
protease. These results also suggested that the bioactivity of YS and MS protein 
hydrolysates could be further enhanced after gastrointestinal digestion. In another 
study conducted by Nongonierma & FitzGerald, (2015), soy hydrolysates generated 
upon in-vitro SGID exhibited DPP-IV inhibitory activity with IC50 values of 1.85 
mg/ml. Overall, from the results obtained for AA and DPP-IV inhibition, it can be 
suggested that both YS and MS proteins demonstrated significant anti-diabetic effects 
with former being more potent. Thus, both YS and MS protein-derived bioactive 
protein hydrolysates may help in glycemic management strategy without any side 
effects. However, further work is needed to fully determine the mechanism of 
inhibitory action, their efficacy under in-vivo conditions and their bioavailability in as 
well as identification of the peptide sequence in the most potent hydrolysates. 
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4.3.3 Inhibition of key enzymes related to obesity by young and mature soybean 
protein hydrolysates 
Anti-obesity activities of MS derived bioactive peptides have been among the 
best explored bioactive properties both in-vitro and in-vivo only after their 
antihypertensive effects. The mechanistic evaluation into anti-obesity action of soy 
peptides has been directed to their inhibition of enzyme related to cholesterol 
biosynthesis known as 3-hydroxy-3-methylglutaryl CoA reductase (HMGCoAR) 
which is linked to their hypolipidemic effect (Kasim et al., 1992; Singh et al., 2021; 
Wang et al., 2018). It is reported that peptide LPYP from the glycinin subunit, and 
IAVPGEVA and IAVPTGVA are potent inhibitors of HMGCoAR (Pak et al., 2005). 
Similarly, KNPQLR, EITPEKNPQLR, and RKQEEDEDEEQQRE obtained from 
glycinin subunit of soy protein were found to be inhibitory to the action of enzyme 
fatty acid synthase activity. Therefore, these studies indicate that peptides obtained 
from the YS and MS could also lead to inhibition of the enzymes that are related with 
fats digestion and absorption in the human body such as pancreatic lipase (LIP) and 
cholesterol esterase (CE). 
4.3.3.1 Pancreatic lipase (LIP) inhibitory activity 
Lipases are the enzymes that digest fats such as triacylglycerol- and 
phospholipases. Gastric and pancreatic lipases are enzymes that catalyze the 
hydrolysis of dietary triacylglycerols which is essential for their absorption by 
enterocytes, to enable the absorption of dietary fat in the body (Mukherjee, 2003). 
Pancreatic LIP (triacylgycerol acyl hydrolase) is the main lipolytic enzyme that is 
synthesized and secreted through the pancreas and plays a major role in the hydrolysis 
of 50 70% of total dietary fats (Birari & Bhutani, 2007). Therefore, the inhibitory 
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activity of pancreatic LIP to delay and inhibit the digestion and absorption of fat, have 
been suggested for the development of anti-obesity agents (Seyedan et al., 2015).  
Similarly, cholesterol is important for the synthesis of steroid hormones, bile 
acids, and vitamin D in the body. Despite that, hypercholesteremia causes the 
formation of plaques in arteries which results in arteriosclerosis and subsequent 
hypertension (Mada et al., 2019). Pancreatic CE is an enzyme, which get secreted from 
pancreas into the intestinal track, is responsible for the hydrolysis of multiple 
substrates such as cholesterol esters, fat-soluble vitamins, triglycerides, and 
phospholipids. CE can regulate the serum cholesterol levels and is involved in 
lipoprotein metabolism and can cause a harmful effect in atherosclerosis processes 
(John et al., 2011). Bioactive peptides of different food products have been 
demonstrated to decrease cholesterol levels. Although LIP and CE inhibitory activity 
of camel milk protein hydrolysates (Jafar et al., 2018; Mudgil et al., 2019b), fermented 
milk (Gil-Rodríguez & Beresford, 2019; Kim & Lim, 2020), and millet grains 
(Jakubczyk et al., 2019) have been studied so far. There are no previous studies on the 
inhibitory activity of LIP and CE by MS and YS protein hydrolysates.  
Results obtained from the present study indicated significant improvement in 
LIP and CE inhibitory activity upon hydrolysis of YS and MS proteins. Specifically, 
flavourzyme generated hydrolysates were more efficient in inhibiting both LIP and CE 
with IC50 values in the range of 65.15 and 32.96 µg/ml protein equivalent for MS 
soybean protein hydrolysates, whereas 30.41 and 27.08 µg/ml protein equivalent for 
YS soybean protein hydrolysates, respectively. Significantly lower LIP and CE-IC50 
values were also observed for alcalase and bromelain generated hydrolysates when 
compared to intact proteins. These results are also in agreement with previously 
published results. For instance, yellow field pea (Pisum sativum L.) hydrolysates 
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produced through alcalase and trypsin hydrolysis showed potent LIP inhibitory 
activities as displayed with their low IC50 values of 3.95 mg/ml and 3.98, respectively 
(Awosika & Aluko, 2019). Similarly, Ngoh et al. (2017) reported that the pinto bean-
derived hydrolysates have inhibited LIP activity ranging from ~23 to ~87%, whereas 
cumin-seed derived hydrolysates and peptides displayed LIP inhibitory potential in the 
range of 50.1 to 54.6% (Siow et al., 2016). The aforementioned studies also indicated 
that the hydrolysates derived from plant proteins could exhibit the inhibitory activity 
of LIP, which also agrees with the obtained results of the YS and MS hydrolysates. 
Not only plant proteins but proteins from dairy stream have also been reported to exert 
potent LIP inhibitory actions (Mudgil et al., 2018). In a study conducted on alcalase, 
bromelain and papain generated hydrolysates from camel milk, displayed a pattern 
similar to the YS hydrolysates where the hydrolysates presented lower IC50 values with 
the increase in hydrolysis time (Mudgil et al., 2018). In silico analysis into the 
inhibitory mechanism of these hydrolysates indicated that the generated peptides exert 
their inhibitory mechanism against LIP through binding to substrate binding unit and 
catalytic binding sites of LIP (Mudgil et al., 2018). 
4.3.3.2 Cholesterol esterase (CE) inhibitory activity 
CE is a pancreatic enzyme present in bile that catalyzes the release of 
cholesterol and free fatty acids from dietary cholesterol esters. CE plays an important 
role in cholesterol metabolism by various mechanism such as regulation of cholesterol 
transportation and conversion of lysine to lysolecithin that is required for micelle 
formation. As such, inhibition of CE can slowdown cholesterol uptake by human body 
indirectly by decreasing the level of cholesterol produced from dietary lipids (Heidrich 
et al., 2004). Although no direct study on the CE inhibitory effects of plant seed 
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proteins has been reported previously, results obtained by Zhong et al. (2007a) 
demonstrated that the hypocholesterolemic effect of soy-derived peptides on mice 
indicated that alcalase derived soy hydrolysate showed a cholesterol micellar solubility 
inhibitory rate of 48.6% which was suggested as a potential hypocholesterolemic 
effect. Similarly, Kobayashi et al. (2012) also reported that fermented soymilk can 
modulate cholesterol metabolism in rats fed with high cholesterol diet. It was 
demonstrated that upon the ingestion of fermented soymilk, the liver weight and fat 
mass of the rats were reduced, lowered cholesterol levels, hepatic triglyceride, and 
plasma total cholesterol level were observed (Kobayashi et al., 2012). Furthermore, it 
was observed that high-protein soymilk has a significant cholesterol-lowering effect 
hen it as replaced ith protein from co s milk completel  (Sirtori et al., 1999). 
Another example of different plant proteins is cumin seed derived peptides 
demonstrated to inhibit cholesterol micelle formation showing an inhibitory effect up 
to 80% (Siow et al., 2016). These studies are in agreement with the results of the 
present study of YS and MS which has shown potential to inhibit cholesterol esterase 
to a significant level. 
CE enzyme inhibition was also demonstrated by camel milk whey protein 
hydrolysates generated by gastric and pancreatic enzymes (Jafar et al., 2018). 
Furthermore, Jemil et al. (2017) reported that the fermented sardinelle protein 
hydrolysates contain bioactive peptides, which significantly reduced hyperlipidemia. 
Similarly, camel milk protein hydrolysates were found to be significantly inhibited the 
activities of CE enzyme under in-vitro conditions (Mudgil et al., 2019b). Similarly, 
various other peptides such as lactostatin and soystatin (Nagaoka, 2018) from -
lactoglobulin and soy, respectively as well as peptide WGAPSL (Zhong et al., 2007b) 
were reported to exert hypocholesterolemic effects via mechanisms like CE inhibition. 
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Overall, as the information related to LIP and CE inhibitory action of protein 
hydrolysates is quite limited, thus more research needs to be performed to elucidate 
the LIP and CE inhibitory effects of such peptides. 
4.3.4 Antioxidant activity by young and mature soybean protein hydrolysates 
Enzymatic hydrolysis has been known to boost the functional and biological 
properties of proteins including antioxidant activities. Antioxidant properties of the 
hydrolysates mainly rely on different factors including the composition of the native 
protein, method of protein isolation, peptide sequence, structure, molecular weight, 
and the degree of hydrolysis (Ajibola et al., 2011). In addition, the antioxidant 
activities of these peptides are also dependent on the sequence of amino acids, and that 
in turn is determined by the specificity of proteases used for hydrolysis that could 
positively affect their antioxidant activities (Coscueta et al., 2016). Bioactive peptides 
exert their antioxidant activities using several mechanisms such as radical scavenging, 
lipid peroxidation inhibition, chelation of metal ion, reduction of free radicals, etc. 
(Sarmadi & Ismail, 2010). Therefore, it is important to use different kinds of 
antioxidant assays in order to elucidate the total antioxidant power of generated 
hydrolysates. The value of Trolox Equivalent Antioxidant Capacity (TEAC) is used as 
an expression of the antioxidant activity that can enable comparing antioxidant 
capability between different laboratories and therefore, results obtained in this study 
are also expressed as TEAC (µg/ml of protein equivalent) (Jara et al., 2018). Overall, 
to estimate the total antioxidant capacity of YS and MS hydrolysates three different 
antioxidant assays with different mechanisms were used.  
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4.3.4.1 Ferric-reducing antioxidant power (FRAP) 
Ferric reducing antioxidant power (FRAP) assay determines the ability of test 
compounds to reduce ferric ion (Fe+3)TPTZ complex to ferrous (Fe+2)TPTZ 
complex that generate a blue color product with absorbance maxima at 593 nm. The 
intensity of blue color developed is directly correlated with reducing capability of test 
compounds (Sbroggio et al., 2016). Intact proteins of YS and MS displayed significant 
antioxidant power and are in-line with previous findings from other researchers. There 
are different plant seed protein hydrolysates that showed FRAP capacities such as 
African yam bean seed (Ajibola et al., 2011), cowpea seed (Olusegun & Emmanuel), 
rice bran (Thamnarathip et al., 2016), mung bean ((Lapsongphon & Yongsawatdigul, 
2013; Sonklin et al., 2018), and cumin seeds (Siow & Gan, 2017). 
The results obtained in the present study indicated that MS protein 
hydrolysates have significantly higher FRAP activity in comparison to YS protein 
hydrolysates. These distinct differences in the FRAP between YS and MS protein 
hydrolysates could be attributed to various factors such as sequence of peptides, 
position of particular amino acids in the sequence, and their accessibility to react with 
ferric ions (Elias et al., 2008). In addition, sequence and presence of 
hydrophobic/aromatic amino acids within the peptides are also reported to affect 
FRAP activities of hydrolysates (Salami et al., 2011). Moreover, the reason could be 
due to the presence of peptides with different molecular sizes and amino acids 
sequences, which could also result in different structural functionality and thus 
reducing capacity of the peptides within the hydrolysates (Meza-Espinoza et al., 2018). 
Overall, hydrolysis of both types of soybean proteins significantly improved the FRAP 
activities of hydrolysates.  
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Additionally, there are several researches that are in-line with the findings of 
the present study which show that soybean protein hydrolysates can act as antioxidant 
compounds by displaying reducing power. Zhang et al. (2019) have reported that 
soybean peptides generated upon alcalase hydrolysis (VVFVDRL, VIYVVDLR, 
IYVVDLR, and IYVFVR) possess FRAP activities in the range of 54.7-79.0 mM. 
Another study reported that the soy crude hydrolysates produced with proteases 
derived from Bromelia pinguin and Bromelia karatas fruits also displayed high FRAP 
values of 8.57- and 8.89-mM TE/g protein, respectively (Meza-Espinoza et al., 2018). 
Furthermore, okara protein hydrolysates also showed increase in FRAP activity with 
the increase in time of hydrolysis and corresponded directly with DH% values. The 
range of TEAC values for FRAP activity were comparative to the values obtained in 
the present study (Sbroggio et al., 2016).  
Nonetheless, several other studies have also reported higher reducing power 
appearing from the low molecular weight hydrolysates (smaller peptides) rather than 
the high molecular weight. For instance, Meza-Espinoza et al. (2018) reported a higher 
FRAP capacity from the low molecular weight fractions (d1 kDa and d5 kDa) of soy 
protein crude hydrolysates. In addition, the smallest fraction of pinto bean protein 
hydrolysates (3 kDa) that was generated by protamex have shown the highest FRAP 
(0.81 mM) (Ngoh & Gan, 2016). Ajibola et al. (2011) have also reported that the 
smallest fraction of the African yam bean seed protein hydrolysate (1 kDa) has 
significant reducing power compared to the fractions with higher molecular weight 
peptides (1 3, 3 5, 5 10 kDa). The results of YS and MS hydrolysates are highly 
indicating that these hydrolysates can be an advantageous ingredient to be utilized as 
antioxidants in nutraceutical and functional food formation. 
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4.3.4.2 2 2 -azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) radical 
scavenging activity 
ABTS radical scavenging activity method is based on measuring the 
discoloration of the ABTS radicals as a result of the presence of antioxidant 
compounds (Coscueta et al., 2016). The results obtained in the present study indicated 
that hydrolyzed YS and MS proteins showed a higher ABTS radical scavenging 
activity compared to their intact proteins. The increase in ABTS radical scavenging of 
hydrolysates correlated well with increase in DH values and are in agreement with 
study conducted by Guan et al. (2018) where a similar positive relationship between 
DH of the soy protein isolate hydrolysates and ABTS radical scavenging activity was 
observed. These results are also in accordance with Sbroggio et al. (2016) where 
increased hydrolysis of okara (soybean by-product) protein hydrolysate produced upon 
alcalase hydrolysis was found to significantly increase the ABTS radical scavenging 
activity from 68.6% to 99.5%. Similarly, flavourzyme induced hydrolysis was also 
reported to increase the ABTS radical scavenging of hydrolysates from 67.2 to 88.2% 
(Sbroggio et al., 2016). The result of the present study also suggests that that 
hydrolysis of YS and MS protein led to an increased in ABTS radical scavenging 
activity when the DH increased. 
Furthermore, previous research on soy protein hydrolysates prepared with the 
peptidases from latex of Maclura pomifera fruit also showed an increase in ABTS 
radical sca enging acti it  ith a TEAC alue of 157.6 moles TE/g of protein and 
are well in agreement with the present results (Jara et al., 2018). Similar ABTS radical 
scavenging activity was also reported by Song et al. (2020) for cottonseed proteins and 
their hydrolysates with values ranging between 568.87  1086.76 M TEAC/mg 
protein equivalent, respectively. The higher ABTS radical scavenging effect of 
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hydrolysates is usually correlated with higher content of positively charged amino 
acids and lower content of negatively charged amino acids (Song et al., 2020). 
Therefore, more investigations are needed towards the identification and 
characterization of individual peptides and their physicochemical properties and their 
mechanistic evaluation towards their inherent antioxidant powers.  
4.3.4.3 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging activity  
The method of DPPH radical scavenging activity is based on the ability of the 
antioxidant compounds to donate a hydrogen atom to the free radical (Sbroggio et al., 
2016). The oil-soluble free DPPH radicals turn into a stable product after accepting 
hydrogen or an electron from the antioxidant generating a non-toxic species that in 
turn is supposed to inhibit the propagation phase of lipid oxidation (Amadou et al., 
2011). The results obtained pertaining to DPPH radical scavenging activity of YS and 
MS protein hydrolysates are represented in Table 8 and depicted that bromelain 
generated hydrolysates showed the highest DPPH radical scavenging activity followed 
by flavourzyme generated hydrolysates. In addition, it was observed that there was a 
positive correlation between time of hydrolysis and DPPH radical scavenging, which 
is similar to the results obtained for ABTS radical scavenging activity. Although intact 
protein of MS was found to be a better scavenger of DPPH radicals, hydrolysates from 
YS protein possessed a better DPPH radical scavenging compared to their intact 
protein indicating that they may possess peptide sequences with potent DPPH radical 
scavenging activities. The inherent radical scavenging capacity of intact proteins from 
YS and MS is related with the capacity of their terminal amino acids residues like Phe, 
Trp, His, Tyr, and Cys, for their capacity to donate electron to DPPH radical and is 
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also reported well in literature that both hydrolyzed and unhydrolyzed proteins have 
the capacity to scavenge DPPH radicals (Kumar et al., 2016).  
Overall, all three enzymes used in generating YS and MS protein hydrolysates 
in this study were able to generate peptides with potent DPPH radical scavenging 
activities. The obtained results were found to be similar to Zhang et al. (2010) where 
soy protein hydrolysates produced by validase and neutral protease were found to be 
a significantly more potent scavengers of DPPH radicals than those produced by 
alkaline protease. Similar trend was also observed by Zheng et al. (2019) in black bean 
(Phaseolus vulgaris L.) protein hydrolysates prepared with bromelain and alcalase 
which exhibited significantly enhanced DPPH scavenging activity compared to 
hydrolysates produced by ficin. The obtained DPPH-TEAC values are also similar to 
those reported for alcalase derived soy sauce protein hydrolysates (Yang et al., 2011). 
Furthermore, fermented soy protein meal hydrolysates obtained after fermentation 
with lactobacillus plantarum LP6 also reported to possess enhanced DPPH radical 
scavenging effects and are attributed to the release of peptides upon hydrolysis of 
proteins upon degradation by microbial proteases (Amadou et al., 2011). The positive 
correlation has been observed between DH values and DPPH radical scavenging 
activity that is similar to those observed for alcalase generated okara protein 
hydrolysates where a progressive increase in DH% also corresponded to increased 
DPPH radical scavenging (Sbroggio et al., 2016). Similarly, Jamdar et al. (2010) also 
reported that as the DH increase, the DPPH radical scavenging activity increased for 
peanut protein hydrolysates. Overall, the results suggest that plant proteins especially 
YS proteins could be used as a significant source of antioxidant peptides.  
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4.3.5 Anti-inflammatory (AI) activities 
Inflammation is considered as one of the prime risk factors for the development 
of various ailments and chronic diseases such as obesity, diabetes, and cancer 
progressions. Generally, infected cells produce various pro-inflammatory cytokines 
that lead to DNA damage and promote or initiate tumor (Kamal et al., 2018). Few 
reports suggest that peptides derived from food products can control these 
inflammatory events by the protection of protein against inflammation induced by 
protein and DNA damage (Iskandar et al., 2013). These reports prompted us to 
investigate the AI properties of soybean-derived protein hydrolysates. 
As indicated in the results section, all YS and MS protein hydrolysates 
displayed significant AI properties through albumin anti-denaturation effect. In 
addition, it was noticed that MS hydrolysates produced by alcalase and bromelain and 
YS hydrolysate produced by bromelain have displayed an increase in AI activity at 2 
and 4 h of hydrolysis and then declined significantly at 6 h. A similar observation was 
recorded by Mudgil et al. (2019a) where alcalase and papain-generated camel milk 
protein hydrolysates showed an increase in AI activities from 3 to 6 h before showing 
a decline at 9 h of hydrolysis. The phenomenon was attributed to the high DH and 
degradation of proteins as a result of papain and alcalase which might have eventually 
degraded the potent AI peptides (Mudgil et al., 2019a). 
Although not direct AI studies have been reported previously but few related 
studies have shown inhibition of pro-inflammatory mediators by soybean-derived 
protein hydrolysates (Martine Villaluenga et al., 2009; Vernaza et al., 2012). 
Martine Villaluenga et al. (2009) studied the AI effect of soybean genotypes enriched 
in E-conglycinin protein hydrolysates produced by alcalase on LPS-induced 
macrophages RAW 264.7 cell line. It was reported that 5 µM of the soy protein 
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hydrolysates have reduced the production of NO (18 35%) and PGE2 (47 71%), and 
also reduced the expression of inducible nitric oxide synthase (iNOS) (31 53%) and 
cycloxygenase-2 (COX-2) (30 52%). In addition, Vernaza et al. (2012) reported that 
the alcalase hydrolysis of the Brazilian soybean protein have shown an AI activity by 
inhibiting the inflammatory markers such as NO, PGE2, COX-2, iNOS, and tumor 
necrosis factor-D (TNF-D) in LPS-induced RAW 264.7 (cell line) macrophages. Since 
the direct evidence related to AI activities of soybean protein hydrolysates are scarce, 
this study highlights the AI potential of soybean protein hydrolysates that could be 
generated at the commercial level through enzymatic hydrolysis. 
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Chapter 5: Conclusion 
 
 
Soybean has been known for the potential health benefits and for its high 
protein content that could be considered as an alternative to animal proteins. Soybean 
(yellow dried seed) bioactive compounds such as protein hydrolysates, peptides, and 
phenolic compounds were explored and reported previously in the literature for their 
different biological activities. However, the data regarding the biological activities of 
YS bioactive compounds and precisely their protein hydrolysates are scarce. 
Therefore, this research project aimed to generate protein hydrolysates from YS and 
MS proteins via enzymatic hydrolysis in-vitro with different enzymes (alcalase, 
bromelain, and flavourzyme). Moreover, the effect of simulated gastric and intestinal 
digestion (SGID) of YS and MS flours on their potential bioactive properties was 
investigated. 
Both YS and MS flours upon in-vitro SGID and their protein hydrolysates 
generated via enzymatic hydrolysis exerted different biological activities. Higher 
antioxidant and AI activities were demonstrated by soybean flours as well as protein 
hydrolysates upon SGID and enzymatic hydrolysis, respectively. The concentration of 
the TPC of YS increased significantly after the simulated gastric digestion and the 
SGID. In addition, it was evident that YS and MS flours have exhibited a variation in 
the inhibitory activity against the diabetes and obesity related enzymatic marker (AA, 
DPP-IV, CE, and LIP) upon simulated gastric digestion followed by a decrease in 
inhibitory activity when subjected to simulated intestinal digestion (P<0.05). While 
for antioxidant activities, MS flour showed a higher FRAP, ABTS radical scavenging 
activity and AI activity compared to YS flour.  
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Protein hydrolysates generated from YS and MS also displayed higher 
inhibitory activity against AA, DPP-IV, CE, and LIP enzymes compared to their intact 
proteins, and the IC50 values of YS and MS hydrolysates varied. The inhibitory activity 
of LIP and DPP-IV enzymes were significantly higher by YS hydrolysates compared 
to MS hydrolysates, while the opposite was evident for MS hydrolysates in inhibiting 
CE enzyme. The DH of MS hydrolysates is higher than YS hydrolysates. Similarly, 
the antioxidant properties such as FRAP, ABTS, and DPPH radical scavenging 
activities as well as AI activities of YS and MS hydrolysates were enhanced upon 
enzymatic hydrolysis (P<0.05). YS hydrolysates were higher in ABTS radical 
scavenging activity and AI activity than MS hydrolysates. Furthermore, MS 
hydrolysates displayed higher FRAP, as well as the hydrolysates produced by 
flavourzyme and bromelain have also displayed higher DPPH radical scavenging 
activity than YS hydrolysates. Overall, the present study showed that the YS protein 
hydrolysates could be an important source of bioactive peptides with multifunctional 
bioactive properties and could be utilized as a potential functional ingredient for food 
fortification. While MS has been extensively studied for the production of protein 
hydrolysates and their application as functional food ingredients have also been 
explored. Further studies on YS, and its compositional analysis and bioactive 
properties should be investigated in detail using different model systems. Furthermore, 
isolation, characterization, fractionation, and identification of the potential bioactive 
peptides in the hydrolysates specifically for the YS protein hydrolysates should be 
carried out. For validation, in-vivo experiments on animal models are also essential to 
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